CME

All Stories

SMSNA remains fully committed to holding a successful in-person meeting at the Westin Kierland in Scottsdale, AZ this October. SMSNA’s priority remains the health and well-being of our community. We are working closely with the Westin Kierland and third-party vendors to implement thorough but adaptable COVID-19 safety protocols. These protocols will meet or exceed all recommendations and safety procedures from the CDC, the State of Arizona, and the City of Scottsdale. Our current preparations include but are not limited to the following:

  • For the safety of all attendees, everyone attending will be required to complete an attestation indicating that they have been fully vaccinated OR, if they are not fully vaccinated, that they will obtain a negative PCR or antigen coronavirus test within 72 hours of their first day at the 2021 SMSNA Annual Fall Scientific Meeting. They should also attest that, regardless of their vaccination status, they will not be attending the meeting if they are ill or have been exposed to COVID-19 within the 14 days preceding the meeting. All attendees will be asked to complete the attestation either as part of registration, or in case already registered through a link provided by us by email. Individuals who do not complete the attestation will not be permitted to enter the meeting.

  • All meeting attendees will be required to wear a mask, regardless of vaccination status, within the assigned SMSNA meeting spaces of the Westin Kierland. Masks will be available at the registration desk. Hand sanitizing stations will be available throughout the hotel including meeting spaces.

  • Due to the necessity to continue social distancing, especially while eating, pre-packed food items will be provided for any meals (boxed if possible) which will allow attendees to take their meal at a location outside of the indoor meeting space. The Welcome Reception is scheduled as an indoor and outdoor event, with the food and drinks only offered outside. The SMSNA Foundation event is scheduled as an outdoor event.
  • The Westin Kierland requires temperature checks for all employees prior to being allowed in the property. They also require all employees to wear a mask. For more information on Marriott’s policy to “travel with confidence during COVID-19” please view their website: https://clean.marriott.com/#service. Marriott is the parent company of the Westin brand of hotels.

SMSNA will continuously evaluate and update our plans and guidelines as new information becomes available and as environmental conditions change. We will continue to share all updates on evolving COVID-19 preparations as we actively work to plan for a healthy and productive event. For the most up to date information, please refer to the SMSNA meeting website.

Sexual Medicine Society of North America, Inc.
22nd Annual Fall Scientific Meeting of the SMSNA
October 21 – 24, 2021
Scottsdale, AZ

Accreditation Statement
accmeIn support of improving patient care, this activity has been planned and implemented by Amedco LLC and Sexual Medicine Society of North America, Inc. (SMSNA). Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians (ACCME) Credit Designation
Amedco LLC designates this live activity for a maximum of 24.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Psychologists (APA) Credit Designation
Amedco LLC designates this activity for a maximum of 24.50 Psychologist contact hours.

The following state boards accept courses from APA providers for Counselors: AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, MD, ME, MO, NC, ND, NH, NE, NJ, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, WA, WI, WY
MI: No CE requirements

The following state boards accept courses from APA providers for MFTs: AK, AR, AZ, CA, CO, CT, DE, FL, GA, IA, ID, IN, KS, MD, ME, MO, NE, NC, NH, NJ, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, WA, WI, WY
MI: No CE requirement

The following state boards accept courses from APA providers for Addictions Professionals: AK, AR, CO, CT, DC, DE, GA, IA, IN, KS, LA, MD, MO, MT, NC, ND, NE, NJ, NM, NY (outstate held)*, OK, OR, SC, UT, WA, WI, WY
MA / MFTs: Participants can self-submit courses not approved by the MAMFT board for review.

The following state boards accept courses from APA providers for Social Workers: AK, AR, AZ, CA, CO, DE, FL, GA, ID, IN, KY, ME, MN, MO, NE, NH, NM, OR, PA, VT, WI, WY

*If the activity is held live in the state of NY, then direct addictions board is required, ie: NAADAC. If the activity is held outside NY, is virtual, enduring or remote, it is considered "outstate" and this reciprocity applies.

Social Workers (ASWB) Credit Designation
aceAs a Jointly Accredited Organization, Amedco is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Amedco maintains responsibility for this course. Social Workers completing this course receive 24.75 GENERAL continuing education credits.

The following state boards accept courses offering ASWB ACE credit for Social Workers: AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, ID, IL, IN, IA, KS, KY, LA, ME, MD, MA, MI, MN, MS, MO, MT, NC, ND, NE, NH, NM, NV, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, VA, WA, WI, WV, WY

*WV accepts ASWB ACE unless activity is live in West Virginia, then an application is required.

The following state boards accept courses offering ASWB ACE credit for Counselors: AK, AR, AZ, CA, CO, CT, DC, FL, GA, IA, ID, IL, IN, KS, MA, MD, ME, MO, ND, NE, NM, NH, NV, OK, OR, PA, TN, TX, UT, VA, WI, WY
AL/Counselors: Activities not providing NBCC approval may be approved by the Board for individual licensees upon receipt of acceptable documentation prior to the activity. Please send course details to your licensing board for approval BEFORE the event. No approvals afterward by the board.
MI: No CE requirement

The following state boards accept courses offering ASWB ACE credit for MFTs: AK, AR, AZ, CA, CO, FL, IA, ID, IN, KS, MD, ME, MO, NC, NE, NH, NM, NV, OK, OR, PA, RI, TN, TX, UT, VA, WI, WY
MA / MFTs: Participants can self-submit courses not approved by the MAMFT board for review.
MI: No CE requirement

The following state boards accept courses offering ASWB ACE credit for Addictions Professionals: AK, CA, CO, CT, GA, IA, IN, KS, LA, MO, MT, ND, NM, NV, OK, OR, SC, WA, WI, WV, WY

American Association of Sexuality Educators, Counselors, and Therapists (AASECT)
Application has been submitted for review.

Download the Learner Notification

1. Registration

Registrations are only accepted if this online registration form has been successfully submitted. No registration form is accepted unless accompanied by full payment.

2. Security

When registering through the internet, your personal and payment details are secured and encrypted. The latest encrypting techniques available are used for data transfer.

3. Confirmation/Payment Obligation

As soon as you have finished your personal registration process for the 22nd Annual Fall Scientific Meeting of SMSNA by clicking the "Register Now" button, you enter into a binding agreement with the organization of this meeting. As a result, you accept the payment obligation and the term of payment that comes along with this agreement.

Your registration will be confirmed by e-mail, giving you an overview of the personal details as filled in by you during the registration process. Furthermore, if you select to pay your registration fee by bank transfer or check, you will receive your invoice attached to your confirmation e-mail. A final e-mail will be sent to you once your payment has been received.

In case you fail to meet the term of payment that is applicable to your registration category (early fee or late fee), the organization is entitled to raise your registration fee to the next category (from early fee to regular fee or from regular fee to last-minute fee).

In case the organization has not received your payment before the start of the meeting, entry to the meeting may be refused without your payment obligation being waived.

4. Correspondence Address

For all correspondence regarding the meeting, the organization will use the e-mail address as provided by you during the registration process.

5. Liability

In registering for the congress, the participants agree that neither the SMSNA Board of Directors, Status Plus nor the Meeting Committee or any of their officers, agents, employees, or representatives assume any liability whatsoever.

6. Insurance

Participants are strongly advised to arrange their own travel, health, and cancellation insurance in the unfortunate case of having to cancel the meeting participation and/or travel and/or hotel accomodation because of illness or other (personal) circumstances.

7. Photography/Image Use Policy

SMSNA reserves the right to ue any images, in any media, captured at the meeting and related events, for promotional activities of future SMSNA activities in general. Individuals who do not wish to have their likeness, in any medium, used by SMSNA, must provide written notice to This email address is being protected from spambots. You need JavaScript enabled to view it..

8. Attendee List

For this meeting, a meeting app is available that will contain an attendee list with personal details of everyone that has registered for the meeting. The attendee list is accesible for all meeting attendees, including industry representatives.

9. Industry Sponsored Sessions

Due to compliance regulations, your first name, last name, and e-mail address (e-mail address only of non-EU participants) will be shared with sponsored sessions organizers if you attend an industry sponsored session.

10. Exhibitors

Your first name, last name, and e-mail address (e-email address only for non-EU participants) will be shared with exhibitors if you visit their booth.

11. Currency

All amounts are stated in US Dollars (USD) and must be paid and/or will be collected in USD.

12. Pending Amounts

Any differences (appearing from incorrect application an/or past deadlines) in registration fees will be collected on-site during the meeting.

13. Payment On-Site

On-site payments can be made either in cash or by using a valid credit card.

14. Registration Cancellation & Refund Policy

Cancellation of your registration and refund requests for registration must be submitted in writing to the SMSNA Executive Office before September 1, 2021. All refund requests will be subject to a USD 100.00 processing fee. No refunds will be made on/after September 1, 2021.

Cancellations must be notified as soon as possible in writing (e-mail or letter) to:
SMSNA Executive Office
14305 Southcross Dr.
Suite 100
Burnsville, MN 55306 USA
Phone: (952) 683 1917
Fax: (952) 314 8212
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
Website: www.smsna.org

2021 Virtual Residents Arena

Wednesday, November 3, 2021

8:00pm Eastern / 7:00pm Central

Join us on Wednesday, November 3 for the Residents Arena, at which the 10 best scoring abstracts submitted by residents to the 22nd Annual Fall Scientific Meeting of SMSNA will be presented by the residents. The 3 best presentations, based on a combination of audience vote (50%) and judges’ scores (50%), will each win $1,000!

Register Now

Moderators and Judges
Johanna Hannan, PhD
Lawrence Jenkins, MD, MBA
Rachel Rubin, MD, IF

10 Best Abstracts submitted by Residents

Innovative Findings Characterizing the Location and Severity of Postoperative Pain Following Inflatable Penile Prosthesis Surgery Managed with Multimodal Analgesia
Avery Braun, DO
Einstein Healthcare Network


When to Suspect Artificial Urinary Sphincter Cuff Erosion: An Analysis of Presenting Signs and Symptoms
Linley Diao, MD
UT Southwestern Medical Center


Cocultured Schwann Cells Rescue Irradiated Pelvic Neuron Outgrowth and Increase Survival
Joshua Randolph, MD
Mayo Clinic School of GME Jacksonville


Artificial Urinary Sphincter Reverses Weight Gain Associated with Post-Prostatectomy Incontinence
Raj Bhanvadia, MD
UT Southwestern Medical Cente
r

Drain Volume Output Following IPP Implantation: An Analysis by Surgical Approach
Michael Tonzi, MD
University of Tennessee College of Medicine at Chattanooga


Cost Analysis of Online Telehealth Platforms Offering Testosterone Therapy
Erin Jesse, MD
University Hospitals Cleveland Medical Center


Impact of Health Literacy on Satisfaction Following Inflatable Penile Prosthesis Surgery
Rohan G. Bhalla, MD
Vanderbilt University Medical Center


The Urethral Microbiome During Inflatable Penile Prosthesis Placement
John M. Williams, MD, MS
Ochsner Clinic Foundation


Decreasing Intraoperative Narcotic Use: Pudendal Nerve Block Prior to Inflatable Penile Prosthesis Implantation
Jeunice Owens-Walton, MD
Medical College of Georgia at Augusta University


Does Revision Without Replacement Increase Infection Risk in Urologic Prosthetics?
Scott P. Campbell, MD
Duke University Medical Center

Emily Jane Willingham, PhD

emily willinghamWillingham earned her bachelor's degree in English and her PhD in biological sciences at The University of Texas at Austin and completed a postdoctoral fellowship in urology at the University of California-San Francisco. She has taught students of all ages, primarily as a university instructor in scientific writing and biology, focusing on physiology, anatomy, developmental biology, genetics, and general science.

Willingham is the 2014 recipient of the John Maddox Prize for standing up for science, a joint initiative of Nature and the Kohn Foundation, that rewards an individual who has faced difficulty and hostility in the course of promoting sound, evidence-based science on a matter of public interest. She also served on the board of the National Association of Science Writers, for which she chaired the Fairness Committee and co-chaired the membership committee. She is a recipient of an Association of Health Care Journalists fellowship award.

phallacy willinghamEmily Willingham is author of Phallacy: Life Lessons from the Animal Penis (Avery, 2020) and The Tailored Brain (Basic Books, 2021). Her writing has been published online at the New York Times, Scientific American, Forbes, the San Francisco Chronicle, the Wall Street Journal, Discover, NOVA, Science, and others. She is also co-author with Tara Haelle of the award-winning book, The Informed Parent (Perigee Books/Penguin), and the author of The Complete IG to College Biology. Her writing focuses on the intersection where society, science, and biases meet. She specializes in examining social perspectives on mental health, sexuality and gender, and parenting, with close attention to unconscious motivations and a practical perspective.

She has been struck by lightning once personally, on a ridge in Yellowstone National Park, and also has once been in a car that was struck by lightning and in an airplane that was zapped. In other words, do not stand too near her.

You can find her on Twitter (@ejwillingham), Instagram (@emily.willingham.phd), and Facebook (@ejwillinghamphd).

Submit Now SMSNA is pleased to announce the 7th annual Essay Prize competition for trainees. Clinical trainees in medicine, surgery and psychology (residents, fellows, medical students, graduate students, nursing students and PA students) are eligible to submit their original research papers, scientific reports, or case reports in sexual medicine for three prizes of $1,500 for the best manuscript in one of the following categories: Male Sexual Health (clinical, surgical, imaging, research) Female Sexual Health (clinical, surgical, imaging, research) Case Report in Sexual Health Manuscripts should also be submitted as abstracts for presentation or poster to the 22nd SMSNA Annual Fall Scientific Meeting in Scottsdale, AZ. Abstract submission is not required for the Case Report in Sexual Health category. Click here for details on Abstract Submission. Manuscripts will be reviewed anonymously and therefore must NOT contain any author(s) or submitting institutions contact information. Any manuscript containing identifying information will not be considered for this prize. Manuscripts will be reviewed by the Essay Prize Review Committee. Winners will be announced at the 22nd SMSNA Annual Fall Scientific Meeting in Scottsdale, AZ. Submission Instructions:  Submissions will be accepted by completing the online form by no later than 11:59 pm EDT, September 1, 2021. Submission should contain the following: Category (Male Sexual Health, Female Sexual Health, or Case Report in Sexual Health) Manuscript Title Authors(s) Contact Information Attachment: Manuscript (with no identifying information) including abstracts, tables and figures, and references. Manuscript Rules of Publication: Original Research Original research papers are scientific reports of original clinical or basic research in the field of sexual medicine. As a general guideline, manuscripts should be 3000 words in length; more extensive manuscripts will be considered and judged on merit; however, authors are urged to be as concise as possible. All manuscripts must include an abstract, a maximum of 7 tables and figures (total), and up to 50 references. More may be accepted if justified. Case Report Reports are concise reports of cases, clinical experience, clinical studies, drug trials, adverse effects, or devices related to sexual medicine. Maximum length is 1750 words; no more than 10 references, and 1 figure/table. Other Information: Trainees are encouraged to submit their manuscript to the Journal of Sexual Medicine , Sexual Medicine Open Access , or Sexual Medicine Reviews . 

Abstract Instructions

  1. Your abstract must be prepared in English.
  2. To ensure that article referees or peer reviewers do not know your identity (as author[s] of the abstract being reviewed), you will need to make sure that you remove any information in the actual abstract (including footnotes and acknowledgments) that could identify you and disguise all references to personally identifiable information such as the research institution where your work was carried out. Also exclude references to grants awarded to named persons, refer to your own references in the third person.
  3. Your abstract word count should NOT exceed 500 words.
  4. Structure of your abstract:
    • Introduction: Describe the background supporting the relevance of the research question.
    • Objective: State the purpose of the study or investigation.
    • Methods: State details on study subjects, techniques, and/or observations/anatlytical methods.
    • Results: Include your main findings, noting statistically significant data.
    • Conclusions: Summarize principal conclusions, emphasizing new and important aspects.
  5. Use standard abbreviations. Place unusual abbreviations between parentheses (...) after the first appearance of the word.
  6. If an abstract is presented at another meeting which is NOT a North American meeting prior to SMSNA 2021, the SMSNA allows for the abstract to be presented at the SMSNA 2021 Annual Fall Scientific Meeting in Scottsdale.
  7. Acknowledgements: If you do not follow these instructions, your abstract may be declined.

Instructions for Video Abstracts

The below criteria must be met for acceptance of video presentation:

  • Maximum duration: 8 minutes
  • File cannot be above 500 MB
  • Videos must have English captions or narration
  • Please ensure that your videos protect patient anonymity and integrity
  • The preferred resolution is 1280x720p (16:9 aspect ratio) HD video
  • Acceptable file formats are mp4, avi, and mpeg4

PLEASE REMOVE ALL PRODUCT LOGOS/NAMES FROM VIDEO - if a video is submitted with the product name/logo included, the video will be disqualified from consideration.

Thursday, October 21, 2021
07:55 a.m. - 10:00 a.m.
Kierland Grand Ballroom 1AB
Basic Science Symposium: The Basic Science / Clinical Science Divide: Bring Down the Wall! - Part 1
Moderators: Kelvin Davies, MSc, PhD & Moses Tar, MD
07:55 a.m. - 08:00 a.m.
Introduction
Speaker: Kelvin Davies, MSc, PhD
08:00 a.m. - 08:20 a.m.
Irradiation/ED: Clinical Perspective: Minimizing Treatment Related Side Effects of Radiotherapy
Speaker: Bridget Koontz, MD
08:20 a.m. - 08:40 a.m.
Irradiation/ED: Basic Science Perspective: The Impact of Radiation on Neurite Viability
Speaker: Johanna Hannan, PhD
08:40 a.m. - 09:00 a.m.
Diabetes and Obesity/Sexual Dysfunction: Clinical Perspective: The Association Between Diabetes and Sexual Dysfunction and Novel Treatment Strategies (pre-clinical/ clinical e.g. stem cell/SWT)
Speaker: Wayne Hellstrom, MD
09:00 a.m. - 09:20 a.m.
Diabetes and Obesity/Sexual Dysfunction: Basic Science Perspective: Activation of TLR9 Results in Corpus Cavernosum Dysfunction in Mice Fed a High Fat Diet
Speaker: Clinton Webb, PhD
09:20 a.m. - 09:40 a.m.
Diabetes and Obesity/Sexual Dysfunction: Basic Science Perspective: Dyslipidemia Associated Stem Cell Damage as a Potential Factor in Development of ED with Type II Diabetes
Speaker: Nestor Gonzalez-Cadavid, PhD
09:40 a.m. - 10:00 a.m.
Basic Science Insights into the Role of the Vaginal Epithelium in Female Genital Arousal (Dys)function
Speaker: Sylvia Suadicani, PhD
08:00 a.m. - 10:00 a.m.
Kierland Grand Ballroom 2
Instructional Course - Restorative Therapies (requires separate registration)
Moderator: Gregory Broderick, MD
08:00 a.m. - 08:20 a.m.
Shockwave Therapy: The Basic Science
Speaker: Guiting Lin, MD
08:20 a.m. - 08:40 a.m.
Shockwave Therapy for ED - A Review of Devices, Outcomes and Recommendations
Speaker: Ranjith Ramasamy, MD
08:40 a.m. - 09:00 a.m.
Shockwave Therapy for Other Urological Conditions
Speaker: Gregory Broderick, MD
09:00 a.m. - 09:20 a.m.
PRP and Stem Cell Therapy: Where Do We Stand?
Speaker: Trinity Bivalacqua, MD, PhD
09:20 a.m. - 09:40 a.m.
Regenerative Therapies and FSD
Speaker: Irwin Goldstein, MD
09:40 a.m. - 10:00 a.m.
Q&A
08:00 a.m. - 10:00 a.m.
Trailblazers Ballroom DE
APP Symposium
Moderator: Cynthia Bednarchik, DNP, CNP
08:00 a.m. - 08:05 a.m.
Welcome
Speaker: Cynthia Bednarchik, DNP, CNP
08:05 a.m. - 08:30 a.m.
Anal Health and Sexual Pleasure: An All-inclusive Discussion of What You Need to Know
Speaker: Aleece Fosnight, MPS, PA-C
08:35 a.m. - 09:00 a.m.
Mental Health and Male Sexual Dysfunction, Impact, Barriers to Care
Speaker: John Dodge, MPS, PA-C
09:00 a.m. - 09:30 a.m.
Racial Health Inequality
Speaker: Lutricia Harrison, APRN-BC,DNP
09:35 a.m. - 09:50 a.m.
Wrap-up Session: Mission, Values, and Objectives for the Advancement and Education of NP/PA
Speaker: Cynthia Bednarchik, DNP, CNP
10:00 a.m. - 11:35 a.m.
Kierland Grand Ballroom 1AB
Basic Science Symposium: The Basic Science / Clinical Science Divide: Bring Down the Wall! - Part 2
Moderators: Kelvin Davies, MSc, PhD & Clinton Webb, PhD
10:00 a.m. - 10:20 a.m.
Prostatectomy/ED: Clinical Perspective: Approaches to Minimize the Nerve Injury that Results in ED Following RP- Does Anything Work?
Speaker: Trinity Bivalacqua, MD, PhD
10:20 a.m. - 10:40 a.m.
Prostatectomy/ED: Basic Science Understanding the Role of Fidgetin-like 2 in CN Growth Following Injury - NOT FOR CE CREDIT
Speaker: Lisa Baker, PhD, MSc
10:40 a.m. - 11:00 a.m.
Prostatectomy/ED: Basic Science Perspective: Sonic Hedgehog Role in Post-surgical Urogenital Complications Associated With Prostatectomy
Speaker: Carol Podlasek, PhD
11:00 a.m. - 11:20 a.m.
The Problem with Patients: Examples of Promising Pre-clinical Treatments for ED that Never Made it Clinically
Speaker: Michael DiSanto, PhD
11:20 a.m. - 11:35 a.m.
Highlight Basic Science Abstracts (3 presentations)
Speaker: Moses Tar, MD
10:00 a.m. - 11:45 a.m.
Kierland Grand Ballroom 2
Fundamentals Course in Women's Sexual Health
Moderator: Noel Kim, PhD
10:00 a.m. - 10:30 a.m.
Identification of Sexual Concerns and Problems
Speaker: Sharon Parish, MD, NCMP
10:30 a.m. - 11:00 a.m.
Diagnosis and Treatment of HSDD
Speaker: Tami Rowen, MD, MS, FACOG
11:00 a.m. - 11:30 a.m.
Diagnosis and Treatment of Genitourinary Syndrome of Menopause
Speaker: Rachel Rubin, MD
11:30 a.m. - 12:00 p.m.
Q&A
11:45 a.m. - 01:00 p.m.
Kierland Grand Ballroom 4
SMSNA Lunch Symposium
01:00 p.m. - 02:00 p.m.
Kierland Grand Ballroom 2
Welcome and Keynote Lecture
Moderator: Faysal Yafi, MD, FRCSC
01:00 p.m. - 01:05 p.m.
Opening remarks
01:05 p.m. - 01:50 p.m.
Life Lessons From the Animal Penis
Speaker: Emily Willingham, PhD
01:50 p.m. - 02:00 p.m.
Q&A
02:00 p.m. - 03:30 p.m.
Kierland Grand Ballroom 2
Ethics in Sexual Medicine
Moderators: Sue Goldstein, BA, CCRC, AASECT-CSE & Casey McCraw, MD
02:00 p.m. - 02:12 p.m.
Secrets in Couples' Therapy
Speaker: Daniel Watter, PhD
02:12 p.m. - 02:24 p.m.
Providing Care to People Who Engage in Kink: Ethical Reflections
Speakers: Anna Randall, DHS, LCSW, MPH & Richard Sprott, PhD
02:24 p.m. - 02:36 p.m.
Ethical Conundrums in Vasectomies and Vasectomy Reversals
Speaker: Mary Samplaski, MD
02:36 p.m. - 02:48 p.m.
Sexual Side Effects Related to Male Childhood Circumcision: Myth or Reality?
Speaker: Elias Wehbi, MD, MSc, FRCSC
02:48 p.m. - 03:00 p.m.
Global Status of Female Genital Mutilation
Speaker: Crista Johnson-Akbagwu, MD, MSc, FACOG
03:00 p.m. - 03:12 p.m.
Cognitive Impairment (Parkinson's, Dementia, etc) and Sex, a Couple's Perspective
Speaker: Daniela Wittmann, PhD, LMSW
03:12 p.m. - 03:24 p.m.
Long-term Sexual Consequences Following Gender Selection in Children with DSD
Speaker: Aron Liaw, MD
03:24 p.m. - 03:30 p.m.
Q&A
02:00 p.m. - 03:30 p.m.
Kierland Grand Ballroom 1AB
Androgens Abstract Session #1
Moderators: John Mulhall, MD & Alexander Tatem, MD
02:00 p.m. - 02:05 p.m.
Long-term Testosterone Therapy Improves Erectile Function and Reduces Mortality in Men with Hypogonadism and Type 2 Diabetes – Updated Results from a Registry Study (#001)
Speaker: Farid Saad
02:05 p.m. - 02:10 p.m.
Subcutaneous Testosterone Enanthate and the Effect of Body Mass Index on Serum Testosterone in Men with Testosterone Deficiency (#002)
Speaker: Martin Miner, MD
02:10 p.m. - 02:15 p.m.
Two-Year Administration Data of an Oral Testosterone Undecanoate (TU) Formulation in Hypogonadal Men (#003)
Speaker: Stanton Honig
02:15 p.m. - 02:20 p.m.
The Effect of Route of Testosterone on Changes in Hematocrit: A Systematic Review and Bayesian Network Meta-Analysis of Randomized Trials (#004)
Speaker: Sirpi Nackeeran
02:20 p.m. - 02:25 p.m.
Continuous Testosterone Therapy with Recombinant FSH & HCG Improves Semen Parameters: A Pilot Study (#005)
Speaker: Tariq S. Hakky
02:25 p.m. - 02:30 p.m.
Effects of Long-term Testosterone Therapy on Erectile Function in Obese Men with Functional Hypogonadism Receiving Long-term Testosterone Therapy- results From a Registry Study (#006)
Speaker: Ahmad Haider
02:30 p.m. - 02:35 p.m.
Prevalence and Severity of Obstructive Sleep Apnea in Men with Polycythemia on Testosterone Therapy (#007)
Speaker: John Mulhall, MD
02:35 p.m. - 02:40 p.m.
Finasteride-Associated Suicide and Depression in Men Treated for Hypogonadism and Impotence (#008)
Speaker: Kevin Campbell, MD
02:40 p.m. - 02:45 p.m.
Safety of Human Chorionic Gonadotropin Monotherapy for Men with Hypogonadal Symptoms and Testosterone >300 ng/dL (#009)
Speaker: Quinn Rainer
02:45 p.m. - 02:50 p.m.
Creatinine: An Inaccurate Measure of Renal Function in Men with Testosterone-Induced Muscle Hypertrophy (#010)
Speaker: Kevin Campbell, MD
02:50 p.m. - 02:55 p.m.
Prevalence and Severity of Obstructive Sleep Apnea (OSA) in Men with Testosterone Deficiency (TD) (#011)
Speaker: John Mulhall, MD
02:55 p.m. - 03:00 p.m.
Early Experience with Subcutaneous Injection of Non-Proprietary Testosterone as an Alternative Approach for Testosterone Replacement (#012)
Speaker: Kevin Alter
03:00 p.m. - 03:05 p.m.
Testosterone Replacement Therapy: Patient Reported Preferences (#013)
Speaker: Charles Loeb
03:05 p.m. - 03:10 p.m.
Erythrocytosis in Subcutaneous Testosterone Replacement Therapy (#014)
Speaker: Tatum Williamson
03:10 p.m. - 03:15 p.m.
Safety of Human Chorionic Gonadotropin Monotherapy for Men with Previous Exogenous Testosterone Use or Replacement Therapy (#015)
Speaker: Quinn Rainer
03:15 p.m. - 03:20 p.m.
Comparison of Prevalence of Polycythemia between Nasal Testosterone Gel vs Intramuscular Testosterone Cypionate: Evaluation of Data from an Ongoing Phase IV, Open-Label, Randomized Clinical Trial (#016)
Speaker: Parris Diaz
02:00 p.m. - 03:30 p.m.
Trailblazers Ballroom DE
Erectile Dysfunction Surgical Abstract Session #1
Moderators: Sherita King, MD & Allen Morey, MD
02:00 p.m. - 02:10 p.m.
To Drain or Not To Drain an Inflatable Penile Prosthesis Implantation? A Multi-institutional Experience Tracking Scrotal Hematoma and Infection Occurrence (#017)
Speaker: Ahmed Ragheb
02:10 p.m. - 02:20 p.m.
Innovative Findings Characterizing the Location and Severity of Postoperative Pain Following Inflatable Penile Prosthesis Surgery Managed With Multimodal Analgesia (#018)
Speaker: Avery Braun
02:20 p.m. - 02:30 p.m.
Evaluation of Gram Positive and Gram Negative Bacteria in a Novel In Vitro Biofilm Model of Penile Prosthesis (#019)
Speaker: Manish Narasimman
02:30 p.m. - 02:40 p.m.
Penile Implant Bacterial Biofilm Profiles Vary by Surgery Indication: An Opportunity to Focus on Peri-operative Care (#020)
Speaker: Paul Chung
02:40 p.m. - 02:50 p.m.
Ectopic Reservoir Placement Following Robotic Prostatectomy: Is it Necessary? (#021)
Speaker: Matthew Mutter
02:50 p.m. - 03:00 p.m.
Drain Volume Output Following IPP Implantation: An Analysis by Surgical Approach (#022)
Speaker: Michael Tonzi
03:00 p.m. - 03:10 p.m.
Does Medicaid Cover Penile Prosthesis Surgery? A State-by-State Analysis (#023)
Speaker: John Barnard
03:10 p.m. - 03:20 p.m.
The Urethral Microbiome During Inflatable Penile Prosthesis Placement (#024)
Speaker: John Williams
03:20 p.m. - 03:30 p.m.
Ethnic Disparities in Penile Prosthesis Surgery: An Analysis of Hispanic Patients (#025)
Speaker: Alfredo Suarez-Sarmiento, Jr.
03:30 p.m. - 04:00 p.m.
Vista Morada Patio
Coffee Break
03:30 p.m. - 04:00 p.m.
Foyer - E-poster Station 1
Peyronie's Disease/Priapism E-poster Session
Moderator: Lawrence Jenkins, MD, MBA
03:30 p.m. - 03:33 p.m.
Uncontrolled Diabetes Mellitus is associated with Complications of Peyronie’s Disease (#170)
Speaker: Jason Levy
03:33 p.m. - 03:36 p.m.
The Effect of Collagenase Clostridium Histolyticum Injection on the Treatment Patterns of Peyronie’s Disease: An Analysis of Large Health Care System Over 15-year Period (#171)
Speaker: Hossein Mirheydar, MD
03:36 p.m. - 03:39 p.m.
Racial Trends in Peyronie’s Disease Treatments: Analysis of the Veterans Health Administration (#172)
Speaker: Sirpi Nackeeran
03:39 p.m. - 03:42 p.m.
Comparison of Collagenase Clostridium Histolyticum to Surgery for the Management of Peyronie’s Disease: A Randomized Trial (#173)
Speaker: Benjamin Green
03:42 p.m. - 03:45 p.m.
Sub-Coronal Inflatable Penile Prosthesis Placement: Patient Satisfaction and Outcomes (#174)
Speaker: Carol Feng
03:45 p.m. - 03:48 p.m.
Could COVID-19 Induced Endothelial Dysfunction Explain New Onset Peyronie's Disease? (#175)
Speaker: Quinn Rainer
03:48 p.m. - 03:51 p.m.
Peyronie’s Disease Does Not Significantly Impact Patient-Reported Outcomes After Penile Prosthesis Implantation (#176)
Speaker: Matthew Ziegelmann, MD
03:51 p.m. - 03:54 p.m.
Differences in Patient Characteristics and Surgical Outcomes in Inpatient vs Outpatient Surgery for Peyronie’s Disease: Contemporary Data from the National Surgical Quality Improvement Program Database (#177)
Speaker: Thomas Max Raheem
03:54 p.m. - 03:57 p.m.
Treatment of Peyronie’s Disease Patients with Collagenase Clostridium Histolyticum: Clinical Significance and Outcomes (#178)
Speaker: Ahmad Al-Qudimat
03:57 p.m. - 04:00 p.m.
Safety and Feasibility of Platelet-Rich Plasma Injections for Peyronie’s Disease: Update From a Single-center Double-blind Placebo-controlled Randomized Trial (#179)
Speaker: Manuel Molina
03:30 p.m. - 04:00 p.m.
Foyer - E-poster Station 2
Transgender Medicine/Reconstruction/Voiding Dysfunction E-poster Session
Moderator: J. Patrick Selph, MD
03:30 p.m. - 03:33 p.m.
A Novel Sacral Erector Spinae Block Reduces Opioid Use After Gender-affirming Vaginoplasty (#180)
Speaker: Kathryn Sawyer
03:33 p.m. - 03:36 p.m.
Perioperative Morbidity of Feminizing Gender Affirmation Surgery: Analysis of the National Surgical Quality Improvement Program (NSQIP) Database (#181)
Speaker: Alice Walton
03:36 p.m. - 03:39 p.m.
Real World Experience with ProACT for Post-prostatectomy Incontinence: First 14 Cases (#182)
Speaker: Phillip Fish
03:39 p.m. - 03:42 p.m.
AdVance and AdVance XP Male Sling Comparison, an Institutional Experience (#183)
Speaker: Kian Ahmadieh
03:42 p.m. - 03:45 p.m.
Does Medicaid Cover Artificial Urinary Sphincter Surgeries? A State-by-State Analysis (#184)
Speaker: Charles Loeb
03:45 p.m. - 03:48 p.m.
Preventing Urinary Fistulae After Artificial Urinary Sphincter Removal: Outcomes of a Standardized Protocol (#185)
Speaker: Jeffery Lin
03:48 p.m. - 03:51 p.m.
Does Medicaid Cover Male Urethral Sling Surgery? A State-by-State Analysis (#186)
Speaker: Charles Loeb
04:00 p.m. - 05:30 p.m.
Kierland Grand Ballroom 2
Sexual Medicine: The Canadian Perspective
Moderators: Sophie Bergeron, PhD & Wayne Hellstrom, MD
04:00 p.m. - 04:12 p.m.
Canadian Legacy of the SMSNA
Speaker: Hossein Sadeghi-Nejad, MD, FACS
04:12 p.m. - 04:24 p.m.
Explaining Socialized Healthcare to Americans
Speaker: Ryan Flannigan, MD
04:24 p.m. - 04:36 p.m.
How I Built a Busy Sexual Medicine Practice
Speaker: Serge Carrier, MD, FRCS(C), MMgmt
04:36 p.m. - 04:48 p.m.
How I Built a Busy IPP Practice
Speaker: Gerald Brock, MD
04:48 p.m. - 05:00 p.m.
How I Built a Busy Infertility Practice
Speaker: Peter Chan, MD
05:00 p.m. - 05:12 p.m.
How I Built a Busy FSD and Transgender Practice
Speaker: Yonah Krakowsky, MD
05:12 p.m. - 05:24 p.m.
Creating a Biopsychosocial Clinic for Sexual Dysfunction After Radical Prostatectomy
Speaker: Andrew Matthew, PhD
05:24 p.m. - 05:30 p.m.
Q&A
04:00 p.m. - 05:30 p.m.
Kierland Grand Ballroom 1AB
Androgens Abstract Session #2
Moderators: Andrew McCullough, MD & Martin Miner, MD
04:00 p.m. - 04:10 p.m.
Testosterone (T) Challenge in Men Post-Radical Prostatectomy (RP) with Profoundly Low Testosterone (#026)
Speaker: Jose Miguel Flores Martinez
04:10 p.m. - 04:20 p.m.
Cost Analysis of Online Telehealth Platforms Offering Testosterone Therapy (#027)
Speaker: Erin Jesse
04:20 p.m. - 04:30 p.m.
Real-World Experience with First FDA-Approved Oral Testosterone Undecanoate Formulation (#028)
Speaker: Robert Dudley
04:30 p.m. - 04:40 p.m.
Temporal Effects of Clomiphene Citrate on Testosterone and Semen Parameters (#029)
Speaker: Tommy Jiang
04:40 p.m. - 04:50 p.m.
Testosterone (T) Recovery Profiles After Short-Term Androgen Deprivation Therapy (ADT) (#030)
Speaker: Jose Miguel Flores Martinez
04:50 p.m. - 05:00 p.m.
Systematic Evaluation of YouTube Content on Testosterone Therapy: The Proliferation of Bro-Science (#031)
Speaker: Zhenyue Huang
05:00 p.m. - 05:10 p.m.
Testosterone Replacement Therapy (TRT) is not Associated with a Higher Risk of DVT: Retrospective Analysis of US Claims Data (#032)
Speaker: Eduardwil Hernandez-Vegas
05:10 p.m. - 05:20 p.m.
Persistent Testosterone Suppression After Cessation of Androgen Deprivation Therapy for Localized Prostate Cancer (#033)
Speaker: Ruben Blachman Braun
05:20 p.m. - 05:30 p.m.
Utility of Directly Measured Free Testosterone in Predicting Benefit of Testosterone Therapy in Men with Hypogonadal Symptoms and Normal Total Testosterone (#034)
Speaker: Nivetha Chandrasekaran
04:00 p.m. - 05:30 p.m.
Trailblazers Ballroom DE
Female Sexual Function Abstract Session
Moderators: Noel Kim, PhD & Tami Rowen, MD, MS, FACOG
04:00 p.m. - 04:10 p.m.
Ethnic Underrepresentation in Validation of Female Sexual Dysfunction Questionnaires (#035)
Speaker: Carissa Redmon
04:10 p.m. - 04:20 p.m.
The Impact of Social Determinants of Health on Female Sexual Function (#036)
Speaker: Jonathan Davila
04:20 p.m. - 04:30 p.m.
Determining Borders of Surgical Excision of the Vestibule Based on Positive CD117 and PGP9.5 Staining of Mast Cells in Women with Neuroproliferative Vestibulodynia (#037)
Speaker: Irwin Goldstein, MD
04:30 p.m. - 04:40 p.m.
The 12:00 Region of the Vestibule: Often Overlooked during Examination and Treatment of Women with Entrance Dyspareunia (#038)
Speaker: Alyssa Yee
04:40 p.m. - 04:50 p.m.
Onset of Flibanserin Treatment Effect in Postmenopausal Women Assessed by Subdomain Scores of the Female Sexual Function Index (FSFI) (#039)
Speaker: James Simon
04:50 p.m. - 05:00 p.m.
Female Genitalia in Pornography: The Source of Labiaplasty Trends? (#040)
Speaker: Alexandra Dubinskaya
05:00 p.m. - 05:10 p.m.
Sexual Activities and Fear-related Reasons for Avoiding Sexual Activities in Early Pregnancy: A Cross-sectional Study (#041)
Speaker: Chi Thanh Phan
05:10 p.m. - 05:20 p.m.
Systemic Estradiol Menopause Management: Return to the Old-Fashioned Way (#042)
Speaker: Sue Goldstein, BA, CCRC, AASECT-CSE
05:20 p.m. - 05:30 p.m.
A Pilot Study of Pre-Operative Vestibular Low Intensity Shockwave Therapy to Decrease Opioid Use Post-Vestibulectomy (#043)
Speaker: Alyssa Yee
05:30 p.m. - 06:30 p.m.
Kierland Grand Ballroom 2
Presidential Lecture and Opening Ceremony
05:30 p.m. - 06:00 p.m.
Presidential Lecture: The Impact of the Pandemia for Sexual Medicine
Speaker: Serge Carrier, MD, FRCS(C), MMgmt
06:30 p.m. - 08:00 p.m.
Vista Morada Patio
Welcome Reception
Friday, October 22, 2021
07:00 a.m. - 08:00 a.m.
Kierland Grand Ballroom 4
Industry Sponsored Breakfast Symposium
08:00 a.m. - 10:00 a.m.
Kierland Grand Ballroom 2
What's the Buzz? Sexual Medicine in 2021
Moderators: Nelson Bennett, MD, FACS & Faysal Yafi, MD, FRCSC
08:00 a.m. - 08:05 a.m.
Urology Care Foundation Update
Speaker: Harris M. Nagler, MD, FACS
08:05 a.m. - 08:20 a.m.
8th Annual Robert J. Krane Lecture - Priapism: From Bench to Bedside and Back
Speaker: Arthur Burnett, MD
08:20 a.m. - 08:29 a.m.
A Summary of the New AUA Disorders of Ejaculation Guidelines
Speaker: Alan Shindel, MD
08:29 a.m. - 08:38 a.m.
A Summary of the New AUA Priapism Guidelines
Speaker: Trinity Bivalacqua, MD, PhD
08:38 a.m. - 08:47 a.m.
Review of SMSNA Position Statement on Restorative Therapies
Speaker: Trinity Bivalacqua, MD, PhD
08:47 a.m. - 08:56 a.m.
Vacuum Therapy for Penile Rehabilitation: Science or Fiction?
Speaker: Run Wang, MD, FACS
08:56 a.m. - 09:05 a.m.
Use of Testosterone Therapy for Women with HSDD
Speaker: Sharon Parish, MD, NCMP
09:05 a.m. - 09:14 a.m.
Insurance Coverage Variation with Advanced Erectile Dysfunction Treatment: An American Perspective
Speaker: Matthew Ziegelmann, MD
09:14 a.m. - 09:23 a.m.
Cost-effectiveness of Sexual Healthcare - International Perspective
Speaker: Rupin Shah, MD
09:23 a.m. - 09:32 a.m.
The Impact of Physician Productivity Models on Access to Sexual Medicine
Speaker: James Dupree, MD, MPH
09:32 a.m. - 09:41 a.m.
COVID and Direct-to-consumer Online Treatments for Male Sexual Dysfunction
Speaker: Aaron Spitz, MD
09:41 a.m. - 09:50 a.m.
Surgical Education During a Pandemic: Limitations, Opportunities, and Lessons
Speaker: Brian Christine, MD
09:50 a.m. - 10:00 a.m.
Q&A
10:00 a.m. - 10:30 a.m.
Vista Morada Patio
Coffee Break
10:00 a.m. - 10:30 a.m.
Foyer - E-poster Station 1
Cancer Survivorship/Mental Health/Miscellaneous E-poster Session
Moderator: Alan Shindel, MD
10:00 a.m. - 10:03 a.m.
Testicular Pain – Not Always What it Seems: A Cross-sectional Assessment of Patients Presenting for Chronic Scrotal Content Pain at a Tertiary Care Center (#187)
Speaker: Michael Sischka
10:03 a.m. - 10:06 a.m.
Effect of Gender on Practice Patterns of Andrology Fellowship Graduates (#188)
Speaker: Britney Lau
10:06 a.m. - 10:09 a.m.
Anal Sex Practices and Rectal Erogenous Zones: An Anatomic Questionnaire Based Study (#189)
Speaker: Alice Walton
10:09 a.m. - 10:12 a.m.
Self-reported Post-vasectomy Fournier's Gangrene Complication Among Practitioners (#190)
Speaker: Linda Huynh
10:12 a.m. - 10:15 a.m.
Physician Assistant Interest in Men’s Health and Other Post-Graduate Sub-Specialty Training (#191)
Speaker: Yashasvi Manektala
10:15 a.m. - 10:18 a.m.
Men with Unusual Sexual Dysfunctions: A Novel Management Algorithm and Long-Term Treatment Outcome (#192)
Speaker: Sue Goldstein, BA, CCRC, AASECT-CSE
10:18 a.m. - 10:21 a.m.
Sexual Function after Burn Injury: “The Bystander Effect” and Other Results from a Survey of Active Medical Providers from the Canadian Burn Association (#193)
Speaker: Michael Pignanelli
10:21 a.m. - 10:24 a.m.
Environmental Toxicants and Male Sexual Dysfunctions (#194)
Speaker: Katherine Ferry
10:24 a.m. - 10:27 a.m.
Utility of Novel Mapping Biopsy for Improvement of Extramammary Paget Disease Outcomes: A Case Series (#195)
Speaker: Rosalie Zurlo
10:00 a.m. - 10:30 a.m.
Foyer - E-poster Station 2
Erectile Dysfunction Medical E-poster Session
Moderators: Justin Parker, MD & Rachel Rubin, MD
10:00 a.m. - 10:03 a.m.
IIEF-EF Improvements are more Pronounced with Nutraceuticals Compared to Placebo Medications: A Systematic Review and Meta-analysis (#196)
Speaker: Mark Arthur
10:03 a.m. - 10:06 a.m.
How Long Does it Take to Achieve Maximal Improvements of Erectile Function in Men with Functional Hypogonadism Receiving Long-term Testosterone Therapy? Results from a Registry Study (#197)
Speaker: Karim Sultan Haider
10:06 a.m. - 10:09 a.m.
Pre- and Post-injection Pain in Patient’s Undergoing First Intracavernosal Injection (#198)
Speaker: Daniela Haehn
10:09 a.m. - 10:12 a.m.
A Free Listing Assessment of Sexual Function and Relationships for Penile Prosthesis and Intracavernosal Injection Therapy for Erectile Dysfunction (#199)
Speaker: Kaitlin Berry
10:12 a.m. - 10:15 a.m.
Hemoglobin A1c does not Predict Severity of Erectile Dysfunction (#200)
Speaker: Amanda Myers
10:15 a.m. - 10:18 a.m.
Characteristics of Patients with Erectile Complaints Referred to a Center of Excellence – Defining Complex Erectile Dysfunction (#201)
Speaker: Daniela Haehn
10:18 a.m. - 10:21 a.m.
Impact of COVID-19 Pandemic in Online Interest in Erectile Dysfunction (#202)
Speaker: Elizabeth Bearrick
10:21 a.m. - 10:24 a.m.
Successful Treatment of Hard Flaccid Syndrome: A case report (#203)
Speaker: Elsa Nico
10:24 a.m. - 10:27 a.m.
Growth Factor Concentration Can Vary in Platelet-Rich Plasma from Men with Erectile Dysfunction (#204)
Speaker: Kajal Khodamoradi
10:30 a.m. - 12:00 p.m.
Kierland Grand Ballroom 2
Inclusion, LGBTQ and Sexual Medicine
Moderators: Irwin Goldstein, MD & Marah Hehemann, MD
10:30 a.m. - 10:39 a.m.
Challenges Facing Women in Sexual Medicine
Speaker: Akanksha Mehta, MD
10:39 a.m. - 10:48 a.m.
Racial and Other Social Disparities in the Treatment of Sexual Dysfunction
Speaker: Denise Asafu-Adjei, MD, MPH
10:48 a.m. - 10:57 a.m.
Work-life Balance for the Surgeon-parent - Male Perspective
Speaker: Kenneth DeLay, MD
10:57 a.m. - 11:06 a.m.
Work-life Balance for the Surgeon-parent - Female Perspective
Speaker: Amy Guise, MD
11:06 a.m. - 11:15 a.m.
Review of Appropriate LGBTQ Nomenclature and How to Address Patients
Speaker: Joshua Gonzalez, MD
11:15 a.m. - 11:24 a.m.
Sexual Health Needs of Transmasculine Individuals
Speaker: Geolani Dy, MD
11:24 a.m. - 11:33 a.m.
Updates in Male-to-female Surgery
Speaker: J. Patrick Selph, MD
11:33 a.m. - 11:42 a.m.
Options for Penile Prosthesis Selection, and Proximal Fixation, in the Transgender Male Patient
Speaker: Maurice Garcia, MD, MAS
11:42 a.m. - 11:51 a.m.
Transgender Patients and Their Partners: Adaptation to Transition
Speaker: Rachel Featherstone, RN, BSN
11:51 a.m. - 12:00 p.m.
Q&A
10:30 a.m. - 12:00 p.m.
Kierland Grand Ballroom 1AB
Genital Cosmetic Surgery
Moderators: Gregory Broderick, MD & Ronald Lewis, MD
10:30 a.m. - 10:39 a.m.
How to Assess Patients for Penile Dysmorphic Disorder
Speaker: Christian Nelson, PhD
10:39 a.m. - 10:48 a.m.
Penile Casts: Are They Ready for Prime Time?
Speaker: Laurence Levine, MD
10:48 a.m. - 10:57 a.m.
Flaps, Grafts and Injections for Penile Enlargement, What's the Data?
Speaker: Matthew Ziegelmann, MD
10:57 a.m. - 11:06 a.m.
Management of Male Penile Cosmetic Surgery Complications
Speaker: James Furr, MD
11:06 a.m. - 11:15 a.m.
Optimizing Cosmesis at the Time of IPP Placement
Speaker: Sherita King, MD
11:15 a.m. - 11:24 a.m.
IPP with Phalloplasty - Ventral
Speaker: Rafael Carrion, MD
11:24 a.m. - 11:33 a.m.
IPP with Phalloplasty - Dorsal
Speaker: Osama Kamal Zaki Mahmoud Shaeer, MD
11:33 a.m. - 11:42 a.m.
Lasers for Vaginal "Rejuvenation": Do They Work?
Speaker: Jessica Yih, MD
11:42 a.m. - 11:51 a.m.
Labiaplasty: Should it be Offered?
Speaker: Barbara Chubak, MD
11:51 a.m. - 12:00 p.m.
Q&A
10:30 a.m. - 12:00 p.m.
Trailblazers Ballroom DE
International Session
Moderators: Billy Cordon, MD & Run Wang, MD, FACS
10:30 a.m. - 10:40 a.m.
ISSM Lecture - Medical Education Challenges During the COVID Pandemic: Strategies for Academic and Community Based Clinicians
Speaker: Gerald Brock, MD
10:40 a.m. - 10:50 a.m.
APSSM Lecture - Prevalence and Risk Factor of Sexual Dysfunction in Asian Countries
Speaker: Hwancheol Son, MD
10:50 a.m. - 11:00 a.m.
SASSM Lecture - Female Sexual Dysfunction - Indian Experience
Speaker: Neelima Deshpande, MD
11:00 a.m. - 11:10 a.m.
SLAMS Lecture - Post-prostatectomy Sexual Health Beyond Penile Rehabilitation
Speaker: Eduardo Miranda, MD, PhD
11:10 a.m. - 11:20 a.m.
ISSWSH Lecture - Sexual Health in Cancer Survivors
Speaker: Sharon Bober, PhD
11:20 a.m. - 11:30 a.m.
ESSM Lecture - Different Patches in Peyronie's Disease: How to Choose
Speaker: Carlo Bettocchi, MD, FECSM
11:30 a.m. - 11:40 a.m.
MESSM Lecture - FGM ...Obstacles to Eliminating it
Speaker: Wafaa Eltantawy, MD
11:40 a.m. - 12:00 p.m.
Q&A
12:00 p.m. - 01:30 p.m.
Kierland Grand Ballroom 4
Industry Sponsored Lunch Symposium
01:30 p.m. - 03:30 p.m.
Kierland Grand Ballroom 2
Wrestlemania 2021: Controversies in Sexual Medicine
Moderators: Run Wang, MD, FACS & Daniela Wittmann, PhD, LMSW
01:30 p.m. - 01:45 p.m.
Space of Retzius Reservoir Placement Should be Abandoned
Speakers: Hossein Sadeghi-Nejad, MD, FACS & Jay Simhan, MD
01:45 p.m. - 02:00 p.m.
Patients with History of Sex Offenses Should be Placed on Hormonal Deprivation Therapy
Speakers: Barbara Chubak, MD & Annamaria Giraldi, MD, PhD
02:00 p.m. - 02:15 p.m.
Oral Therapies Should be Considered First Line in the Treatment of PGAD
Speakers: Irwin Goldstein, MD & Caroline Pukall, PhD, Cpsych
02:15 p.m. - 02:30 p.m.
Psychosexual Therapy Should be Considered First Line Therapy for the Management of Delayed Ejaculations
Speakers: Michael Perelman, PhD & Alan Shindel, MD
02:30 p.m. - 02:45 p.m.
All Peyronie's Cases can be Treated with Penile Plication
Speakers: Laurence Levine, MD & Allen Morey, MD
02:45 p.m. - 03:00 p.m.
Industry Sponsored Research Should not be Published in Medical Journal
Speakers: John Mulhall, MD & Landon Trost, MD
03:00 p.m. - 03:15 p.m.
Immediate Penile Prosthesis Placement Should be Recommended for the Management of Prolonged Priapism
Speakers: Gregory Broderick, MD & Tobias Kohler, MD, MPH
03:15 p.m. - 03:30 p.m.
Total, Not Free Testosterone, Should be Used to Diagnose and Treat Hypogonadism
Speakers: Mohit Khera, MD & Abraham Morgentaler, MD
01:30 p.m. - 03:30 p.m.
Trailblazers Ballroom DE
Basic Science Abstract Session
Moderators: Trinity Bivalacqua, MD, PhD & Kelvin Davies, MSc, PhD
01:30 p.m. - 01:40 p.m.
Cocultured Schwann Cells Rescue Irradiated Pelvic Neuron Outgrowth and Increase Survival (#044)
Speaker: Joshua Randolph
01:40 p.m. - 01:50 p.m.
Leptin-LEPR-Desert Hedgehog Signaling Induced Leydig Stem Cells Differentiation in Testis is Modulated by EMT Inducing Transcription Factors which Binds to LEPR (#045)
Speaker: Kajal Khodamoradi
01:50 p.m. - 02:00 p.m.
Intracavernous Injection of Botulinum Toxin may Improve Erectile Function in a Bilateral Cavernous Nerve Injury Animal Model (#046)
Speaker: Jeffrey Campbell, MD
02:00 p.m. - 02:10 p.m.
Synergy Between Sildenafil and Topically Delivered Nitric-oxide in Eliciting an Erectile Response in a Rat Model of Radical Prostatectomy (#047)
Speaker: Moses Tar, MD
02:10 p.m. - 02:20 p.m.
Tumor Necrosis Factor- α (TNF-α) and Rho-Associated Kinase 2 (ROCK2) Inhibitors Improve Erectile Function in a Bilateral Cavernous Nerve Injury Rat Model (#048)
Speaker: James Liu
02:20 p.m. - 02:25 p.m.
Endogenous Effects of Leptin on Leydig Stem Cell Differentiation through Desert Hedgehog Signaling Pathway (#049)
Speaker: Alexandra Dullea
02:25 p.m. - 02:30 p.m.
Dual Strategy with Intracavernosal Implantation of Adipose-derived Stem Cells and Daily Oral L-arginine Optimize Recovery of and Cavernosal Functions after Cavernous Nerve Injury in Rats (#050)
Speaker: Didem Yilmaz-Oral
02:30 p.m. - 02:35 p.m.
Differences in the Gut Microbiome Composition Between Men with Erectile Dysfunction and A Matched Cohort: A Pilot Study (#051)
Speaker: Mohamad M Osman
02:35 p.m. - 02:40 p.m.
Leptin Effects on Leydig Stem Cell Differentiation are Specific to Patients BMI (#052)
Speaker: Kajal Khodamoradi
02:40 p.m. - 02:45 p.m.
Low-intensity Extracorporeal Shockwave Therapy as an Adjunct to Xiaflex® in the Treatment of Peyronie’s Disease (#053)
Speaker: Ayman Soubra
02:45 p.m. - 02:50 p.m.
Sonic Hedgehog Signaling in Corpora Cavernosal Cells from Prostatectomy, Diabetic, Hypertension and Peyronie’s Patients with Erectile Dysfunction (#054)
Speaker: Sarah Martin
02:50 p.m. - 02:55 p.m.
Methamphetamine-Induced Vaginal Lubrication & Associated Hormonal Changes (#055)
Speaker: Maggie Mott
02:55 p.m. - 03:00 p.m.
Whole Exome Sequencing Identifies a Rare Mutation in NACAD as a Possible Cause of COVID orchitis in Brothers (#056)
Speaker: Rohit Reddy
03:00 p.m. - 03:05 p.m.
Pathway Enrichment Analysis of Microarray Data from Human Penis of Diabetic and Peyronie’s Patients, in Comparison with Diabetic Rat Erectile Dysfunction Models (#057)
Speaker: Timothy Searl
03:05 p.m. - 03:10 p.m.
Treatment with levothyroxine and testosterone ameliorated erectile dysfunction in rat model of propylthiouracil-induced hypothyroidism (#058)
Speaker: Fatmanur Korkmaz
01:30 p.m. - 03:30 p.m.
Kierland Grand Ballroom 1AB
Peyronie's Disease Abstract Session
Moderators: Mike Hsieh, MD & Yooni Yi, MD
01:30 p.m. - 01:40 p.m.
Collagenase Clostridium Histolyticum Treatment for Peyronie’s Disease: Analysis of Outcomes and Cumulative Benefits After Each Injection Cycle (#059)
Speaker: Matthew Ziegelmann, MD
01:40 p.m. - 01:50 p.m.
Improved Peyronie’s Disease Curvature Outcomes Using a More Aggressive Collagenase Technique (#060)
Speaker: Alissa Tyler
01:50 p.m. - 02:00 p.m.
Penile Extra-Tunical Graft Reconstruction of Peyronie's Disease Concavity Deformities (#061)
Speaker: Linley Diao
02:00 p.m. - 02:05 p.m.
Changes in Point of Maximal Curvature During Collagenase Clostridium Histolyticum Injections for Peyronie’s Disease (#062)
Speaker: Trevor Price
02:05 p.m. - 02:10 p.m.
Evaluating Different Low-intensity Extracorporeal Shockwave Therapy Intensities in the Treatment of Peyronie’s Disease in a Rat Model (#063)
Speaker: Joseph Kim
02:10 p.m. - 02:15 p.m.
Development of a Machine Learning Algorithm for at Home Curvature Assessment (#064)
Speaker: Luke Witherspoon
02:15 p.m. - 02:20 p.m.
Standardizing Sonographic Descriptors of Peyronie’s Plaques (#065)
Speaker: Daniela Haehn
02:20 p.m. - 02:25 p.m.
Novel 3D MRI Fusion Penile Imaging Modality for Peyronie's Disease: A Pilot Study (#066)
Speaker: Joshua Pincus
02:25 p.m. - 02:30 p.m.
Postoperative Progress of Modified Grid Incision and Sealing with Collagen Fleece for Treatment of Peyronie’s Disease (#067)
Speaker: Suntae Ahn
02:30 p.m. - 02:35 p.m.
Incidence of Secondary Intervention for Peyronie’s Disease after Collagenase Clostridium Histolyticum (#068)
Speaker: Sirpi Nackeeran
02:35 p.m. - 02:40 p.m.
Xiaflex® Treatment for Peyronie’s Disease May Improve Penile Curvature Degree With No Effect on the Loss on Penile Length in Post-marketing Analysis (#069)
Speaker: Jacob W. Greenberg
02:40 p.m. - 02:45 p.m.
The SAPOC Technique: A Novel Approach Utilizing Multiple Slices Around Point of Maximal Curvature for the Correction of Penile Curvature at the Time of Penile Prosthesis Placement in Patients with Severe Peyronie’s Disease (#070)
Speaker: Jonathan Clavell-Hernandez, MD
02:45 p.m. - 02:50 p.m.
Adult Patient’s Opinions on Surgical Correction of Congenital Penile Curvature (#071)
Speaker: Matthew Ziegelmann, MD
02:50 p.m. - 02:55 p.m.
Eight injections of Collagenase Clostridium Histolyticum May Be Effective in Calcified Plaques (#072)
Speaker: Isaac Zucker
02:55 p.m. - 03:00 p.m.
The Value of the International Index of Erectile Function (IIEF) in Characterizing the Erectile Function in Patients with Peyronie’s Disease (#073)
Speaker: Jacob W. Greenberg
03:00 p.m. - 03:05 p.m.
Does Treating a Penile Plaque with Collagenase Clostridium Histolyticum Lead to Changes in Vascular Characteristics? (#074)
Speaker: Ayman Soubra
03:05 p.m. - 03:10 p.m.
Peyronie’s Disease: Identification of Patients Requiring Additional Therapy (#075)
Speaker: Niki Parikh
03:10 p.m. - 03:15 p.m.
A Majority of Cases of Peyronie’s Disease Exist in High-Risk Pedigrees (#076)
Speaker: Ben Christiansen
03:15 p.m. - 03:20 p.m.
Verapamil for Peyronie’s Disease: A Systematic Review and Meta-analysis of Effectiveness and Patient Reported Outcomes (#077)
Speaker: Alvin Christopher Lavadia
03:20 p.m. - 03:25 p.m.
CT Imaging of Complex Calcified Peyronie’s Disease (#078)
Speaker: Christian Ericson
03:25 p.m. - 03:30 p.m.
Outcomes of Collagenase Clostridium Histolyticum in Men with Congenital Penile Curvature (#079)
Speaker: Holli Burgon
03:30 p.m. - 04:00 p.m.
Vista Morada Patio
Coffee Break
03:30 p.m. - 04:00 p.m.
Foyer - E-poster Station 1
Female Sexual Function/Miscellaneous E-poster Session
Moderator: Ashley Winter, MD
03:30 p.m. - 03:33 p.m.
Preliminary Results From a Multicenter Study on the Use of a New Device for the Treatment of Genito Pelvic Pain Disorders (#205)
Speaker: Jesus Eugenio Rodriguez Martinez
03:33 p.m. - 03:36 p.m.
Unexpected Therapeutic Responses in Sexual Function in Women Prescribed Flibanserin for Hypoactive Sexual Desire Disorder (#206)
Speaker: Irwin Goldstein, MD
03:36 p.m. - 03:39 p.m.
Trigger Point Needle Release of Pudendal Nerve Entrapment: a Non-Surgical, In-Office Procedure (#207)
Speaker: Teresa Wood
03:39 p.m. - 03:42 p.m.
Misrepresentation of Female Sexual Behavior in Pornography (#208)
Speaker: Alexandra Dubinskaya
03:42 p.m. - 03:45 p.m.
Hormonal Imbalances Association to Persistent Genital Arousal Disorder in Females (#209)
Speaker: Jacob Tannenbaum
03:45 p.m. - 03:48 p.m.
A Review of Sexual Function Following Genital Burns: An Understudied, Morbid, and Rare Condition (#210)
Speaker: Katherine Ferry
03:48 p.m. - 03:51 p.m.
Outcomes and Satisfaction after Penile Silicone Implant Surgery (#211)
Speaker: Morgan Salkowski
03:51 p.m. - 03:54 p.m.
New Findings Regarding the Influence of Assistants on Intraoperative Inflatable Penile Prosthesis Complications (#212)
Speaker: Rutul Patel
04:00 p.m. - 05:30 p.m.
Kierland Grand Ballroom 2
Voiding dysfunction and Urinary incontinence
Moderators: William Brant, MD & Gregory Lowe, MD
04:00 p.m. - 04:09 p.m.
Finasteride and Psychiatric Issues and Suicidality - What's the Data?
Speaker: Alexander Tatem, MD
04:09 p.m. - 04:18 p.m.
Impact of In-office BPH Procedures on Ejaculatory Function
Speaker: Dean Elterman, MD, MSc, FRCSC
04:18 p.m. - 04:27 p.m.
How to Best Preserve Sexual Function in Men with Large Prostates
Speaker: Charles Welliver, MD
04:27 p.m. - 04:36 p.m.
AUS Considerations in Men with Prior IPP Placement
Speaker: O. Lenaine Westney, MD
04:36 p.m. - 04:45 p.m.
AUS - What Does the Future Look Like?
Speaker: Brian Christine, MD
04:45 p.m. - 04:54 p.m.
Role of Testosterone in Urethral Reconstructive Surgery
Speaker: Billy Cordon, MD
04:54 p.m. - 05:03 p.m.
Urethroplasty and Sexual Function
Speaker: Benjamin Breyer, MD
05:03 p.m. - 05:12 p.m.
Mid-urethral Slings and Female Sexual Dysfunction
Speaker: Nicole Szell, DO
05:12 p.m. - 05:21 p.m.
Effects of Bowel and Urinary Incontinence on a Couple's Sexuality
Speaker: Anne Pelletier Cameron, MD
05:21 p.m. - 05:30 p.m.
Q&A
04:00 p.m. - 05:30 p.m.
Kierland Grand Ballroom 1AB
Erectile Dysfunction Medical Abstract Session
Moderators: Helen Bernie, DO, MPH & Bruce Kava, MD
04:00 p.m. - 04:10 p.m.
Does the Risk of Obstructive Sleep Apnea (OSA) Affect Erectile Function Recovery (EFR) After Radical Prostatectomy (RP)? (#080)
Speaker: Jose Miguel Flores Martinez
04:10 p.m. - 04:20 p.m.
Assessing Online Symptom Checker Accuracy in Diagnosing Men’s Health Conditions (#081)
Speaker: Rutul Patel
04:20 p.m. - 04:30 p.m.
Utility of Ceramide Testing in Men with Erectile Dysfunction (#082)
Speaker: Manaf Alom
04:30 p.m. - 04:40 p.m.
Virtual Intracavernosal Injection Training During the COVID Pandemic (#083)
Speaker: Christine Zarowski
04:40 p.m. - 04:45 p.m.
Evaluating the Impact of Time Between Radical Prostatectomy (RP) and Adjuvant Radiation Therapy (RT) on Erectile Function Recovery (EFR) (#084)
Speaker: Jose Miguel Flores Martinez
04:45 p.m. - 04:50 p.m.
Effect of Stem Cell Infusion Therapy on Sexual Function in Men and Women with Type 2 Diabetes and Metabolic Syndrome: Results from the ACESO & CERES Clinical Trials (#085)
Speaker: Russell Saltzman
04:50 p.m. - 04:55 p.m.
Direct-to-Consumer vs. Traditional Prescriptions of PDE5 inhibitors: A Contemporary Cost-Analysis (#086)
Speaker: Douglas Schneider
04:55 p.m. - 05:00 p.m.
Vascular and Erectile Tissue Health Changes Pre- and Post- Low Intensity Shockwave Treatment of the Erect Penis (#087)
Speaker: Maria Uloko, MD
05:00 p.m. - 05:05 p.m.
Lidocaine Incorporated Alprostadil-phentolamine Urethral Gel for Erectile Dysfunction: Patient Tolerability and Satisfaction (#088)
Speaker: Rachel Pham
05:05 p.m. - 05:10 p.m.
Are There Differences in Stretched Flaccid Penile Length Versus Erectile Penile Length in Men with Erectile Dysfunction? (#089)
Speaker: Jose Miguel Flores Martinez
05:10 p.m. - 05:15 p.m.
A Comparison of the Psychosocial Impact of Penile Prosthesis and Intracavernosal Injection Therapy for Erectile Dysfunction Using the Self-Esteem and Relationship (SEAR) Questionnaire (#090)
Speaker: Taylor Tidwell
05:15 p.m. - 05:20 p.m.
Impact of Neoadjuvant Androgen Deprivation Therapy (NADT) on Erectile Function Recovery (EFR) after Radical Prostatectomy (RP) (#091)
Speaker: Jose Miguel Flores Martinez
05:20 p.m. - 05:25 p.m.
Presence and Etiology of Erectile Dysfunction in Peyronie’s Disease as Demonstrated by Color Doppler Duplex Ultrasound (#092)
Speaker: Daniela Haehn
04:00 p.m. - 05:30 p.m.
Trailblazers Ballroom DE
Cancer Survivorship, Mental Health and Miscellaneous Abstract Session
Moderators: Brian Le & Daniel Watter, PhD
04:00 p.m. - 04:10 p.m.
Acceptance and Commitment Therapy to Increase Compliance to Intracavernosal Injection Use (ICI) Following Radical Prostatectomy (RP): Preliminary Results from a Randomized Control Trial (#093)
Speaker: Christian Nelson, PhD
04:10 p.m. - 04:20 p.m.
Anabolic-Androgenic Steroid Use is Associated with Major Depressive Disorder and Suicide Attempt: Analysis of a Multi-National Database (#094)
Speaker: Mehul Patel
04:20 p.m. - 04:30 p.m.
Initial Validation of the Radical Prostatectomy Questionnaire (RPQ): A New Patient Reported Outcome (PRO) to Assess Sexual Function following Radical Prostatectomy (RP) (#095)
Speaker: Christian Nelson, PhD
04:30 p.m. - 04:35 p.m.
TASHRA’s Core Competencies: The Development and Introduction of Clinical Competencies for the Treatment of Kink Populations (#096)
Speaker: Stephen Ratcliff
04:35 p.m. - 04:40 p.m.
Efficacy of RestoreX Penile Traction Therapy in Improving Penile Length and Erectile Function Post Prostatectomy (#097)
Speaker: Andrew Zganjar
04:40 p.m. - 04:45 p.m.
Patient Perspectives of the Implementation of a Prostate Cancer Survivorship Clinic: A Pilot Qualitative Analysis (#098)
Speaker: George Koch
04:45 p.m. - 04:50 p.m.
Comparison of Sexual Concerns Between Patients with Prostate Cancer and Their Partners (#099)
Speaker: John Mulhall, MD
04:50 p.m. - 04:55 p.m.
Sexual Health Problems and Their Association with Psychological Distress: Investigating the Role of Dyadic Coping Behaviors among Young Adult Breast Cancer Survivors and Partners (#100)
Speaker: Chiara Acquati, PhD, MSW
04:55 p.m. - 05:00 p.m.
Penile Prosthesis Utilization After Radical Cystoprostatectomy for Bladder Cancer (#101)
Speaker: Megan Prunty
05:00 p.m. - 05:05 p.m.
Assessment of Work-Related Musculoskeletal Pain in Urologic Microsurgeons (#102)
Speaker: Douglas Schneider
05:05 p.m. - 05:10 p.m.
Testicular Microlithiasis Defines a Subgroup of Azoospermic Men with Low Rates of Sperm Retrieval (#103)
Speaker: Snir Dekalo
05:10 p.m. - 05:15 p.m.
Reporting of Level 1 Evidence in Peyronie’s Disease Publications- A Systematic Review (#104)
Speaker: Raevti Bole
05:15 p.m. - 05:20 p.m.
Efficacy and Safety of Hyaluronic Acid Filler Injection as Compared to Polylactic Acid Filler for Temporary Penile Augmentation: A Multi-center, Patient/evaluator-blinded, Randomized Control Trial with a Safety Extension. (#105)
Speaker: Suntae Ahn
05:20 p.m. - 05:25 p.m.
Premenstrual Dysphoric Disorder on Youtube: a Quality Analysis (#106)
Speaker: Mariam Kyarunts
05:25 p.m. - 05:30 p.m.
Outcomes for Chronic Pelvic and Genital Pain Using Through an Interdisciplinary Pain Rehabilitation Program (#107)
Speaker: Reza Roshandel
05:30 p.m. - 06:00 p.m.
Kierland Grand Ballroom 4
SMSNA Business Meeting (members only)
06:00 p.m. - 07:00 p.m.
Vista Morada Patio
Young Clinicians Mixer
Saturday, October 23, 2021
07:00 a.m. - 08:00 a.m.
Kierland Grand Ballroom 4
Industry Sponsored Breakfast Symposium
08:00 a.m. - 10:00 a.m.
Kierland Grand Ballroom 2
Updates on Penile Prosthesis Surgery
Moderators: Culley Carson, MD, John Mulcahy, MD, PhD, Sung Hun Park, MD & Steven Wilson, MD
08:00 a.m. - 08:09 a.m.
Eligibility For and Ethics of Denying IPP to Patients
Speaker: Christian Nelson, PhD
08:09 a.m. - 08:18 a.m.
Assessing Patient Satisfaction with IPP Surgery
Speaker: Carolyn Salter, MD
08:18 a.m. - 08:27 a.m.
Treating the IPP Patient's Female Partner with Dyspareunia
Speaker: Ashley Winter, MD
08:27 a.m. - 08:36 a.m.
From Prostatectomy to IPP Placement, A Novel Algorithm
Speaker: Paul Perito, MD
08:36 a.m. - 08:45 a.m.
Pump it Up! A Comparison of Various Pumps
Speaker: Justin Parker, MD
08:45 a.m. - 08:54 a.m.
Novel Strategies for the Management of Common Non-infectious IPP Complications
Speaker: Jonathan Clavell-Hernandez, MD
08:54 a.m. - 09:03 a.m.
Diabetes and IPP Infections: Making Sense of Conflicting Evidence
Speaker: Faysal Yafi, MD, FRCSC
09:03 a.m. - 09:12 a.m.
IPP Salvage in 2021
Speaker: Aaron Lentz, MD
09:12 a.m. - 09:21 a.m.
IPP Improvements - What's in the Pipeline?
Speaker: Sevann Helo, MD
09:21 a.m. - 09:46 a.m.
Head-scratchers! Roundtable Management of Complex IPP Cases
Speakers: Rafael Carrion, MD, Gerard Henry, MD & LeRoy Jones, MD
09:46 a.m. - 10:00 a.m.
Q&A
10:00 a.m. - 10:30 a.m.
Vista Morada Patio
Coffee Break
10:00 a.m. - 10:30 a.m.
Foyer - E-poster Station 1
Peyronie's Disease/Priapism/Erectile Dysfunction Surgical E-poster Session
Moderator: Nelson Bennett, MD, FACS
10:00 a.m. - 10:03 a.m.
A Population-based Analysis of Predictors to Penile Surgical Intervention among Inpatients with Acute Priapism (#213)
Speaker: Albert Ha
10:03 a.m. - 10:06 a.m.
Reconstruction of AUS Cuff Erosion: Defect Size Predicts Prognosis (#214)
Speaker: Samantha Nealon
10:06 a.m. - 10:09 a.m.
Exploring the Use of Exchange Transfusion in the Surgical Management of Priapism in Sickle Cell Disease: A Population-Based Analysis (#215)
Speaker: Albert Ha
10:09 a.m. - 10:12 a.m.
Early Data Supporting Ventral Onlay Pseudospongioplasty for Penile Urethral Strictures (#216)
Speaker: Tim Demus
10:12 a.m. - 10:15 a.m.
Health Care Provider Knowledge and Attitudes about Erectile Dysfunction and Penile Implants (#217)
Speaker: C. Scott Collins
10:15 a.m. - 10:18 a.m.
Evaluating the Relationship Among Erectile Dysfunction, Prostate Cancer Treatment Type and Inflatable Penile Prosthesis (IPP) Implantation (#218)
Speaker: Tejash Shah
10:18 a.m. - 10:21 a.m.
Corporal Excavation and Grafting for Inflatable Penile Prosthesis Implantation in Severe Corporal Fibrosis (#219)
Speaker: Jolie Shen
10:21 a.m. - 10:24 a.m.
Time to presentation of Peyronie’s Disease in the era of injections and information (#220)
Speaker: Lisa Ly
10:00 a.m. - 10:30 a.m.
Foyer - E-poster Station 2
Ejaculation/Orgasm/Epidemiology/Androgens E-poster Session
Moderator: Helen Bernie, DO, MPH
10:00 a.m. - 10:03 a.m.
Impact of Environmental and Socioeconomic Factors on Semen Quality in the United States (#221)
Speaker: Jason Levy
10:03 a.m. - 10:06 a.m.
Pharmacovigilance Analysis of Reports of Sexual Dysfunction Associated with Finasteride Use: Implications for the Post-Finasteride Syndrome (#222)
Speaker: David-Dan Nguyen
10:06 a.m. - 10:09 a.m.
Women in Medicine: Career vs Family. Can we have both? (#223)
Speaker: Niki Parikh
10:09 a.m. - 10:12 a.m.
Clinical Experience of our First 50 Patients with Testosterone Undecanoate Capsules (Jatenzo) (#224)
Speaker: Alyssa Yee
10:12 a.m. - 10:15 a.m.
Male Hypogonadism Significantly Increases the Risk of Perinatal Birth Complications: Retrospective Analysis of US Claims Data (#225)
Speaker: Eduardwil Hernandez-Vegas
10:15 a.m. - 10:18 a.m.
Is Testosterone Really Your Sex Hormone: Sexual practices as Defined by Testosterone Concentration (#226)
Speaker: Kevin Campbell, MD
10:18 a.m. - 10:21 a.m.
Effect of Prescription Drug Monitoring Programs on Testosterone Prescriptions (#246)
Speaker: Evan Mulloy
10:30 a.m. - 12:00 p.m.
Kierland Grand Ballroom 2
Effects of Lifestyle on Sexual Health
Moderators: Michael Eisenberg, MD & Bruce Kava, MD
10:30 a.m. - 10:39 a.m.
Environmental Toxins and Sexual Health/Fertility
Speaker: Cigdem Tanrikut, MD
10:39 a.m. - 10:48 a.m.
Endocrine Disruptors and Sexual Health/Fertility
Speaker: Sriram Eleswarapu, MD, PhD
10:48 a.m. - 10:57 a.m.
How Vitamin Deficiencies Can Impact Sexual Health
Speaker: Nicolas Ortiz, MD
10:57 a.m. - 11:06 a.m.
OTC Supplements and Sexual Function
Speaker: Nelson Bennett, MD, FACS
11:06 a.m. - 11:15 a.m.
Effects of Sleep Pathology on Hormones and Sexual Function
Speaker: Anand Shridharani, MD
11:15 a.m. - 11:24 a.m.
Reiki, Pilates, Yoga and Sex
Speaker: Lawrence Jenkins, MD, MBA
11:24 a.m. - 11:33 a.m.
Mindful Meditation - Increasing Sexual Arousal
Speaker: Lori Brotto, PhD, Rpsych
11:33 a.m. - 11:42 a.m.
The Microbiome and Men's Health
Speaker: Petar Bajic, MD
11:42 a.m. - 11:51 a.m.
A Year Later, What do we know about COVID, Sex and Fertility?
Speaker: David Shin, MD
11:51 a.m. - 12:00 p.m.
Q&A
10:30 a.m. - 12:00 p.m.
Kierland Grand Ballroom 1AB
Hormones
Moderators: Larry Lipshultz, MD & Omer Raheem, MD
10:30 a.m. - 10:39 a.m.
Anti-aging Hormonal Therapies: All you need to know
Speaker: Jason Kovac, MD, PhD, FRCSC
10:39 a.m. - 10:48 a.m.
Hormonal Management of Special Populations
Speaker: Mike Hsieh, MD
10:48 a.m. - 10:57 a.m.
Testosterone and Advanced/Metastatic Prostate Cancer
Speaker: Landon Trost, MD
10:57 a.m. - 11:06 a.m.
Effects of Hormones on Bone Health
Speaker: Kelli Gross, MD
11:06 a.m. - 11:15 a.m.
The "Other Hormones" and Sexual Function
Speaker: Ryan Smith, MD
11:15 a.m. - 11:24 a.m.
Oral Testosterone: Ready for Prime Time?
Speaker: Mohit Khera, MD
11:24 a.m. - 11:33 a.m.
Hormonal Strategies in the Pediatric Transgender Patient
Speaker: Nicole Mihalopoulos, MD, MPH
11:33 a.m. - 11:42 a.m.
Hormonal Replacement in the Pre-Menopausal Woman
Speaker: Juliana Kling, MD, MPH
11:42 a.m. - 11:51 a.m.
Can Male Hormone Replacement Destabilize the Couple by Increasing Desire Discrepancy
Speaker: Daniela Wittmann, PhD, LMSW
11:51 a.m. - 12:00 p.m.
Q&A
10:30 a.m. - 12:00 p.m.
Trailblazers Ballroom DE
Video Session
Moderators: Rafael Carrion, MD & Tobias Kohler, MD, MPH
10:30 a.m. - 10:45 a.m.
Video Highlights from VJPU 2020-2021
Speaker: Jeffrey Loh-Doyle, MD
10:45 a.m. - 10:55 a.m.
Placement of ProACT Device in a Man with Persistent Leakage with AUS (#163)
Speaker: Phillip Fish
10:55 a.m. - 11:05 a.m.
SST and The Frozen Pump (#164)
Speaker: Engy Habashy
11:05 a.m. - 11:15 a.m.
IPP Cylinder Extrusion. Our Experience and Approach (#165)
Speaker: Engy Habashy
11:15 a.m. - 11:25 a.m.
CT Cavernosography Technique (#166)
Speaker: James Trussler
11:25 a.m. - 11:35 a.m.
New Bipolar Radiofrequency Sealing tool for Transdermal Vasectomy in the Rabbit Model: a Paradigm Shift in Vasectomy Technique? (#167)
Speaker: Ryan Griggs
11:35 a.m. - 11:45 a.m.
Extratunical Grafting and Penile Plication for Peyronie's Disease (#168)
Speaker: Kathryn Sawyer
11:45 a.m. - 11:55 a.m.
Red Sky in Morning: A Case of Concurrent Hematospermia and Anorgasmia (#169)
Speaker: Alyssa Yee
12:00 p.m. - 01:30 p.m.
Kierland Grand Ballroom 4
Industry Sponsored Lunch Symposium
01:30 p.m. - 03:30 p.m.
Kierland Grand Ballroom 2
Genital Anatomy and Pain
Moderators: Elise De, MD & Joshua Langston, MD
01:30 p.m. - 01:40 p.m.
Practical Step-by-step Tutorial to Diagnosing and Treating Common STIs
Speaker: Jason Jameson, MD
01:40 p.m. - 01:50 p.m.
Testosterone, Alopecia and Acne
Speaker: Hossein Mirheydar, MD
01:50 p.m. - 02:00 p.m.
Anatomy of Female and Male Pelvic Pain
Speaker: Elise De, MD
02:00 p.m. - 02:10 p.m.
Sleep-related Painful Erections
Speaker: Premal Patel, MD
02:10 p.m. - 02:20 p.m.
Hard-flaccid Syndrome, Is it real and how do you treat it?
Speaker: Laith Alzweri, MD
02:20 p.m. - 02:30 p.m.
Chronic Orchalgia, A pain in the ...
Speaker: Amy Pearlman, MD
02:30 p.m. - 02:40 p.m.
POP-Quiz on Female Anatomy for the Men's Health Specialist
Speaker: Rachel Rubin, MD
02:40 p.m. - 02:50 p.m.
Female Genital Lichen Sclerosus - From Diagnosis to Treatment
Speaker: Alexis Chesrow, MD
02:50 p.m. - 03:00 p.m.
Shockwave Therapy for the Management of PGAD
Speaker: Irwin Goldstein, MD
03:00 p.m. - 03:10 p.m.
Psychological Impact of Genital Pain on Couple's Sexual Function
Speaker: Claire Postl, MA, LPCC
03:10 p.m. - 03:20 p.m.
The Role of the Physical Therapist in Pelvic/Genital Pain - What happens behind the scenes?
Speaker: Julie Sarton, PT, DPT, WCS
03:20 p.m. - 03:30 p.m.
Q&A
01:30 p.m. - 03:30 p.m.
Kierland Grand Ballroom 1AB
Erectile Dysfunction Surgical Abstract Session #2
Moderators: Martin Gross, MD & Edward Karpman, MD
01:30 p.m. - 01:40 p.m.
Impact of Health Literacy on Satisfaction Following Inflatable Penile Prosthesis Surgery (#108)
Speaker: Rohan Bhalla
01:40 p.m. - 01:50 p.m.
Caprini Risk Score is Shockingly High in Penile Prosthesis Surgery Patients (#109)
Speaker: Engy Habashy
01:50 p.m. - 02:00 p.m.
Acne, Folliculitis and Post-Operative Infection Rates of Penile Prosthetic Implants (#110)
Speaker: Edward Choi
02:00 p.m. - 02:05 p.m.
Decreasing Intraoperative Narcotic Use: Pudendal Nerve Block Prior to Inflatable Penile Prosthesis Implantation (#111)
Speaker: Rashid Sayyid
02:05 p.m. - 02:10 p.m.
Does Revision Without Replacement Increase Infection Risk in Urologic Prosthetics? (#112)
Speaker: Scott P. Campbell
02:10 p.m. - 02:15 p.m.
Expedited algorithm for IPP following Radical Prostatectomy (#113)
Speaker: Alfredo Suarez-Sarmiento, Jr.
02:15 p.m. - 02:20 p.m.
Patient Risk Factors for Prolonged Opioid Dependence Following Primary Inflatable Penile Prosthesis Placement Managed with Multimodal Analgesia (#114)
Speaker: Avery Braun
02:20 p.m. - 02:25 p.m.
Two Cases of “Drained and Retained” Inflatable Penile Prosthesis and Artificial Urinary Sphincter Reservoirs causing Small Bowel Obstruction (#115)
Speaker: Justin Loloi
02:25 p.m. - 02:30 p.m.
Dorsal Artery Branches to the Corpora Cavernosa (#116)
Speaker: James Trussler
02:30 p.m. - 02:35 p.m.
Erosion of Inflatable Penile Prosthesis with Prolonged Foley Catheterization in the COVID-19 Era (#117)
02:35 p.m. - 02:40 p.m.
Does Irrisept Dipping/Irrigation Adversely Affect the Hydrophilic Coating of Titan Implants? (#118)
Speaker: Ryan Griggs
02:40 p.m. - 02:45 p.m.
Current Practices in High and Low Volume Centers Regarding Corporotomy Localization During Penoscrotal Inflatable Penile Implant Surgery (#119)
Speaker: John Barnard
02:45 p.m. - 02:50 p.m.
Does Partner Involvement Reduce Unanticipated Postop Visits Following Penile Prosthesis? (#120)
Speaker: Amanda Swanton
02:50 p.m. - 02:55 p.m.
Factors Associated With Inflatable Penile Prosthesis Underutilization After Prostate Cancer Treatment (#121)
Speaker: George Abdelmalek
02:55 p.m. - 03:00 p.m.
Increasing Utilization of Outpatient Surgery for Inflatable Penile Prosthesis Placement: Contemporary Data from the National Surgical Quality Improvement Program Database (#122)
Speaker: Thomas Max Shelton
03:00 p.m. - 03:05 p.m.
Patient Perception, Rather Than Magnitude of Objective Improvement, Predicts Desire for Treatment Amongst Men Undergoing Penile Shockwave Therapy (#123)
Speaker: Danly Omil-Lima
03:05 p.m. - 03:10 p.m.
Immediate Salvage with Inflatable Penile Prosthesis in an Infected Field: A Contemporary Multi-institutional Cohort (#124)
Speaker: Daniel Jiang
03:10 p.m. - 03:15 p.m.
Extrinsic Compression of Inflatable Penile Prosthesis Secondary to Prone Positioning for COVID-19 Pneumonia: A Case Series of Two Patients (#125)
Speaker: Carol Feng
03:15 p.m. - 03:20 p.m.
Hypertension and Low Cholesterol as Risk Factors for Infection after Penile Prosthesis Surgery (#126)
Speaker: Justin Loloi
03:20 p.m. - 03:25 p.m.
Penile Prosthesis Now An In office Procedure: A Single Center Experience In The US (#127)
Speaker: Tariq S. Hakky
03:25 p.m. - 03:30 p.m.
Perioperative Morbidity of Penile Prosthesis Placement with Concurrent Surgery: Analysis of the National Surgical Quality Improvement Program Database (#128)
Speaker: Mahmoud Khalil
01:30 p.m. - 03:30 p.m.
Trailblazers Ballroom DE
Ejaculation, Orgasm, Epidemiology, Miscellaneous Abstract Session
Moderators: Marc Rogers, MD & Hossein Sadeghi-Nejad, MD, FACS
01:30 p.m. - 01:40 p.m.
Anal Sex and Sexual Function Satisfaction: A Comprehensive (and Critical) Review of Current Medical Literature (#129)
Speaker: Alice Walton
01:40 p.m. - 01:50 p.m.
Risk Factors for Post-Vasectomy Semen Analysis Non-Adherence in Home-based and Local Lab-based Testing (#130)
Speaker: Jacob Zipkin
01:50 p.m. - 01:55 p.m.
Ejaculation Profiles in Men after Irreversible Electroporation for Prostate Cancer (#131)
Speaker: Jose Miguel Flores Martinez
01:55 p.m. - 02:00 p.m.
Hematospermia and Its Sexual Ramifications: A Systematic Review (#132)
Speaker: Rob Drury
02:00 p.m. - 02:05 p.m.
Pelvic Floor HIFEM in Men Improves Ejaculation (#133)
Speaker: Judson Brandeis
02:05 p.m. - 02:10 p.m.
Prevalence of Sexual Dysfunction in Parkinsonian Men: A Literature Review (#134)
Speaker: Yousef Rafati
02:10 p.m. - 02:15 p.m.
Impedance Rates for Novel Bipolar Radiofrequency Sealing Tool for Transdermal Vasectomy: A Rabbit Model (#135)
Speaker: Tariq S. Hakky
02:15 p.m. - 02:20 p.m.
Small Diameter Penile Implants: A Survey on Current Utilization and Review of Literature (#136)
Speaker: Scott Campbell
02:20 p.m. - 02:25 p.m.
Proper Circumferential Sizing of Penile Implants (#137)
Speaker: Alfredo Suarez-Sarmiento, Jr.
02:25 p.m. - 02:30 p.m.
Is Reddit a Reliable Source for Information on Erectile Dysfunction Treatment? (#138)
Speaker: Nicholas Sellke
02:30 p.m. - 02:35 p.m.
Concerns About Fertility Found to Be Major Cause Of COVID-19 Vaccine Hesitancy in the United States (#139)
Speaker: Parris Diaz
02:35 p.m. - 02:40 p.m.
COVID-19 is Associated with New Onset Erectile Dysfunction: Insights From a Multinational Registry (#140)
Speaker: Kevin Chu
02:40 p.m. - 02:45 p.m.
Association of Poly-tobacco Use with Erectile Dysfunction: Findings from the Population Assessment of Tobacco and Health (PATH) Study (#141)
Speaker: Omer Raheem, MD
02:45 p.m. - 02:50 p.m.
The Efficacy of Written Symptom Questionnaires for the Management of Erectile Dysfunction (#142)
Speaker: Rohan Bhalla
02:50 p.m. - 02:55 p.m.
User Characteristics of Unique Men’s Health Website (#143)
Speaker: Manaf Alom
02:55 p.m. - 03:00 p.m.
Analyzing the Impact of Diabetes on Erectile Function Recovery After Radical Prostatectomy (#144)
Speaker: Jose Miguel Flores Martinez
03:00 p.m. - 03:05 p.m.
Testing a Transdermal Nitric Oxide Booster With a Novel Technology to Quantify Total Penile Vascularity and Volume Using Tissue Segmentation Technology Applied to Ultrasound (#145)
Speaker: Judson Brandeis
03:05 p.m. - 03:10 p.m.
What´s Up With Our Patients 3 Years After Finishing Penile Rehabilitation Study Programs and 5 Years After nsRP? (#146)
Speaker: Andreas Bannowsky
03:10 p.m. - 03:15 p.m.
Critical Underdiagnosis and Undertreatment of Sexual Health Issues in Male Kidney Transplant Recipients (#147)
Speaker: Alvaro Santamaria
03:15 p.m. - 03:20 p.m.
Racial Disparities in Sexual Health Care Received by Kidney Transplant Recipients in a Metropolitan Area (#148)
Speaker: Alvaro Santamaria
03:30 p.m. - 04:00 p.m.
Vista Morada Patio
Coffee Break
03:30 p.m. - 04:00 p.m.
Foyer - E-poster Station 1
Erectile Dysfunction Surgical E-poster Session
Moderator: Sherita King, MD
03:30 p.m. - 03:33 p.m.
The Clinical Significance of Imperfection: Do Asymmetry or Occult Curvature Matter in Penile Prosthesis Placement? (#227)
Speaker: Raevti Bole
03:33 p.m. - 03:36 p.m.
Reservoir Distance from Critical Pelvic Structures: Radiographic Comparison of High Submuscular and Space of Retzius Inflatable Penile Prosthesis Placement Techniques (#228)
Speaker: Mehraban Kavoussi
03:36 p.m. - 03:39 p.m.
Global Trends in Prevalence, Treatments, and Costs of Penile Prosthesis for Erectile Dysfunction in Men (#229)
Speaker: Taylor P. Kohn
03:39 p.m. - 03:42 p.m.
Boston Scientific vs. Coloplast: A Prospective Analysis of a Single High-volume Surgeon’s Inflatable Penile Prosthesis Experience (#230)
Speaker: Eusebio Luna
03:42 p.m. - 03:45 p.m.
Radiographic Assessment of Inflatable Penile Prosthesis Reservoir Location Variability in Contemporary Practice (#231)
Speaker: Mehraban Kavoussi
03:45 p.m. - 03:48 p.m.
Patient Perception of Penile Size and Device after Penile Implant Revision for Mechanical Failure (#232)
Speaker: Engy Habashy
03:48 p.m. - 03:51 p.m.
“Dipping Time” for Irrisept Solution on Titan Inflatable Penile Prosthesis Hydrophilic Coating: No Difference From 1 to 60 minutes (#233)
Speaker: Ryan Griggs
03:51 p.m. - 03:54 p.m.
Analyzing the Quality of YouTube Videos on Inflatable Penile Prosthesis Surgery (#234)
Speaker: Rutul Patel
04:00 p.m. - 05:30 p.m.
Kierland Grand Ballroom 2
Pregnancy, Infertility and Sex
Moderators: Noel Kim, PhD & Sharon Parish, MD, NCMP
04:00 p.m. - 04:10 p.m.
Hormonal Options for the Infertile Man
Speaker: James Hotaling, MD
04:10 p.m. - 04:20 p.m.
Varicoceles, Fertility and Hormones
Speaker: Bobby Najari, MSc
04:20 p.m. - 04:30 p.m.
Sex During Pregnancy, All you need to know
Speaker: Tami Rowen, MD, MS, FACOG
04:30 p.m. - 04:40 p.m.
Roles of Pre- and Post-partum PT on Female Sexual Function
Speaker: Tara Sullivan, DPT
04:40 p.m. - 04:50 p.m.
Updates on Contraception Strategies
Speaker: Nannan Thirumavalavan, MD
04:50 p.m. - 05:00 p.m.
War and Sex: Veterans Injuries Affecting Sex and Fertility
Speaker: Timothy Tausch, MD
05:00 p.m. - 05:20 p.m.
SSTAR Lecture - Pornography Use and Couples' Sexual Health: Much Ado About Nothing?
Speaker: Sophie Bergeron, PhD
05:20 p.m. - 05:30 p.m.
Q&A
04:00 p.m. - 05:30 p.m.
Kierland Grand Ballroom 1AB
Peyronie's Disease
Moderators: Lawrence Hakim, MD, FACS & Eric Laborde, MD
04:00 p.m. - 04:08 p.m.
Future Imaging Modalities for Peyronie's Disease
Speaker: Omer Raheem, MD
04:08 p.m. - 04:16 p.m.
Extended Indications for Collagenase Clostridium Histolyticum
Speaker: Ashley Tapscott, DO
04:16 p.m. - 04:24 p.m.
Challenges with the Management of Peyronie's Disease after the Withdrawal of CCH in Canada
Speaker: Jeffrey Campbell, MD
04:24 p.m. - 04:32 p.m.
Head-to-head Comparison of Various Injection Options for Peyronie's Disease
Speaker: Peter Tsambarlis, MD
04:32 p.m. - 04:40 p.m.
Restorative Therapies for Peyronie's Disease, What's the Data?
Speaker: Seth Cohen, MD, MPH
04:40 p.m. - 04:48 p.m.
Traction vs VED, When to use Which?
Speaker: Helen Bernie, DO, MPH
04:48 p.m. - 04:56 p.m.
Management of Distal Penile Narrowing and Other Unusual Peyronie Presentations
Speaker: Marah Hehemann, MD
04:56 p.m. - 05:04 p.m.
Extratunical Grafting for Indentation and Hourglass Deformity
Speaker: Amjad Alwaal, MD, MSc, FRCSC
05:04 p.m. - 05:12 p.m.
Is Manual Modeling Dead? Best Strategies for Penile Straightening at the Time of IPP Placement
Speaker: Wayne Hellstrom, MD
05:12 p.m. - 05:20 p.m.
Associated Depression and the Impact on the Couple: The Role of a Mental Health Therapist
Speaker: Sharon Bober, PhD
05:20 p.m. - 05:30 p.m.
Q&A
04:00 p.m. - 05:30 p.m.
Trailblazers Ballroom DE
Transgender Medicine/Reconstruction/Voiding Dysfunction Abstract Session
Moderators: Maurice Garcia, MD, MAS & Jonathan Warner, MD
04:00 p.m. - 04:10 p.m.
Medical, Gender Dysphoria, and Quality-of-Life Benefits of Pre-Vaginoplasty Bilateral Orchiectomy (#149)
Speaker: Robert Victor
04:10 p.m. - 04:20 p.m.
When to Suspect Artificial Urinary Sphincter Cuff Erosion: An Analysis of Presenting Signs and Symptoms (#150)
Speaker: Linley Diao
04:20 p.m. - 04:30 p.m.
Factors that Drive Patient Satisfaction in Early Recovery Period After Minimally Invasive Surgical Therapy (MIST) for BPH: a Sub-Analysis of PUL and Rezum (#151)
Speaker: William Schiff
04:30 p.m. - 04:35 p.m.
Effectiveness of Pudendal Nerve Blocks on Postoperative Pain Control and Reduction in Opioid Usage after Gender-affirming Vaginoplasty (#152)
Speaker: Patrick Chin
04:35 p.m. - 04:40 p.m.
Gender-Affirming Vaginoplasty: A Patient Perspective on Informational Needs (#153)
Speaker: Alexi Millman
04:40 p.m. - 04:45 p.m.
Post-Phalloplasty Urinary Function Test: A Novel Outcome Instrument to Capture Urinary Dysfunction and Quality of Life after Phalloplasty (#154)
Speaker: James Liu
04:45 p.m. - 04:50 p.m.
Requirement of Mental-health Referral Letters for Staged and Revision Genital Gender-Affirming Surgeries:  An Unsanctioned Barrier to Care (#155)
Speaker: Maurice Garcia, MD, MAS
04:50 p.m. - 04:55 p.m.
Where to Draw the Line: Understanding Preferences in Mucosal Collar Length After Circumcision (#156)
Speaker: Michael Callegari
04:55 p.m. - 05:00 p.m.
An Alternative Option for Gender-Affirming Revision Vaginoplasty: The Tubularized Urachus-Peritoneal Hinge Flap (#157)
Speaker: Maurice Garcia, MD, MAS
05:00 p.m. - 05:05 p.m.
Artificial Urinary Sphincter Reverses Weight Gain Associated with Post-Prostatectomy Incontinence (#158)
Speaker: Raj Bhanvadia
05:05 p.m. - 05:10 p.m.
Efficacy, Safety, and Sexual Dysfunction Outcomes of Water Vapor Thermal Therapy (Rezum) in Patients with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Updated Systematic Review (#159)
Speaker: Mustufa Babar
05:10 p.m. - 05:15 p.m.
Management of New Complications from Prostatic Urethral Lift (#160)
Speaker: Tariq S. Hakky
05:15 p.m. - 05:20 p.m.
300 Patient Experience with Same Day Surgery for Artificial Urinary Sphincter Insertion - A Safe and Efficient Option (#161)
Speaker: Benjamin Dropkin
05:20 p.m. - 05:25 p.m.
Defining Factors Predictive of Persistent Climacturia After Radical Prostatectomy (#162)
Speaker: Jose Miguel Flores Martinez
05:30 p.m. - 06:30 p.m.
Northern Sky Terrace
APP Networking Session
Sunday, October 24, 2021
07:30 a.m. - 08:00 a.m.
Vista Morada Patio
Breakfast
08:00 a.m. - 09:45 a.m.
Kierland Grand Ballroom 2
Take Home Messages
Moderators: Helen Bernie, DO, MPH & Lawrence Jenkins, MD, MBA
08:00 a.m. - 08:10 a.m.
Female Sexual Function
Speaker: Maria Uloko, MD
08:10 a.m. - 08:20 a.m.
Male Medical
Speaker: Aram Loeb, MD
08:20 a.m. - 08:30 a.m.
Male Surgical
Speaker: Thomas Masterson, MD
08:30 a.m. - 08:40 a.m.
Peyronie's Disease
Speaker: John Taylor Barnard, MD
08:40 a.m. - 08:50 a.m.
Androgens
Speaker: Kevin Campbell, MD
08:50 a.m. - 09:00 a.m.
Transgender/Reconstruction
Speaker: Adam Baumgarten, MD
09:00 a.m. - 09:10 a.m.
Voiding Dysfunction/Incontinence
Speaker: Niels Johnson, MD
09:10 a.m. - 09:20 a.m.
Basic Science
Speaker: Joshua Randolph
09:20 a.m. - 09:30 a.m.
Mental Health
Speaker: Chiara Acquati, PhD, MSW
09:45 a.m. - 10:00 a.m.
Kierland Grand Ballroom 2
Closing
Non-discussed Video Presentations
Videos
Penile Invagination and Corporal Excavation for Penile Prosthesis Placement in Severe Corporal Fibrosis (#235)
Speaker: Christopher Kim
Revision Clitorolabiaplasty and Urethroplasty After Gender-Affirming Vaginoplasty (#236)
Speaker: Alexandra Millman
Gender-Affirming Phalloplasty with Anterolateral Thigh Flap (#237)
Speaker: Alexandra Millman
A Novel Algorithm for Peyronie's Management At the Time of Penile Prosthesis to Maximize Length Without Elevation of the Neurovascular Bundle (#238)
Speaker: Felicia Balzano
The Tunneling Technique: A Universal Approach for Salvage Penile Prosthetic Implantation in Severely Scarred Corporal Bodies (#239)
Speaker: Ahmed Ragheb
Cylinder Realignment for Impending Inflatable Penile Prosthesis Erosion (#240)
Speaker: Ahmed Ragheb
Salvage of Infected Penile Prosthesis using Novel High-Pressure Pulse Irrigation System Adapted to Urological Use in Conjunction with a new Antimicrobial Solution (#241)
Speaker: Alex Shteynshlyuger
Revision Vaginoplasty with Abdominal Full-Thickness Skin Graft (#242)
Speaker: Alexandra Millman
Single Port Robotic-Assisted Removal of an Eroded Inflatable Penile Prosthesis Reservoir and Repair of an Associated Bladder Fistula (#243)
Speaker: Daniel Simon
Penile Entrapment by Metal Ring: A Video Guide to Surgical Removal (#244)
Speaker: Zachary Glaser
Penuma® Concealed Surgery Technique Featuring A New Scrotal Incision (#245)
Speaker: James Elist

Subscribe for our Newsletter!

Image